Our Experts

Meet Your Care Team

Prof. Dr. Humaid Alshamsi

Chief Executive Officer Burjeel Cancer Institute

Book Appointment

stethoscope Medical Oncology

flag_2 UAE

work_history 25 Years of Experience

globe Arabic, English

Book Appointment

Biography

Professor Humaid Obaid Al-Shamsi serves as Chief Executive Officer of Burjeel Cancer Institute in Abu Dhabi, UAE. He is President of the Emirates Oncology Society and holds a leadership role in the Gulf Cancer Society. He is Visiting Professor at Harvard Medical School at Harvard University and Visiting Scientist at Dana-Farber Cancer Institute, Full Professor of Oncology at the Ras Al Khaimah Medical and Health Sciences University in Ras Al Khaimah, UAE. An Adjunct Professor of Oncology at the College of Medicine, University of Sharjah, and Honorary Professor at Gulf Medical University in Ajman, UAE. He graduated with honors from University College Cork, Ireland, in 2004. He completed his residency in internal medicine at McMaster University, Canada, followed by a fellowship in medical oncology and advanced training in gastrointestinal (GI) oncology and palliative care. He is the first Emirati to complete a fellowship in palliative care in the UAE. During his training at McMaster University, he received multiple awards, including the Outstanding Senior Resident of the Year Award by the Medical staff Association of McMaster University (2012) and the Jeff Ginsberg Subspecialty Resident Award (2012). Professor Al-Shamsi is the first Emirati to be promoted to the rank of Professor in Oncology in the UAE. He serves as Chairman for Colorectal Cancer in the MENA region, appointed by the National Comprehensive Cancer Network® (NCCN) in the USA. He is the only member of the Lung Cancer Policy Network in the MENA region, which aims to advance lung cancer research and screening globally. He is Chairman of the Oncology and Hematology Fellowship Training Program for the National Institute for Health Specialties in the United Arab Emirates. He is the only member in the GCC of the WIN Consortium, an international organization representing all stakeholders in personalized cancer medicine worldwide. He is board-certified in both internal medicine and oncology by the UK, USA (ABIM), and Canada (FRCPC). He is the only physician in the UAE with a subspecialty fellowship certification and training in gastrointestinal oncology and the first Emirati to train and complete a clinical post-doctoral fellowship in palliative care. He is the first physician globally to be documented as having been granted the well-recognized royal fellowships from the royal colleges of FRCP (Canada), FRCP (Ireland), FRCP (London), FRCP (Edinburgh), FRCP (Glasgow), and the American College of Physicians, FACP (USA), reflecting broad international recognition of his clinical and academic standing.

From 2014 to 2017, he served as Assistant Professor at the University of Texas MD Anderson Cancer Center. He was the first (inaugural) graduate of the Sheikh Khalifa Bin Zayed Program for outstanding UAE Physicians training in 2016 — a prestigious national scholarship/training initiative. He has authored more than 200 peer-reviewed articles published in leading journals including CA: A Cancer Journal for Clinicians , Cancer , JAMA Oncology , Lancet Oncology , Journal of Clinical Oncology , The Oncologist , BMC Cancer , and many others. He received the Publication of the Year 2020 award from The Oncologist journal for an international paper on COVID-19 and cancer management. He is a regular peer reviewer for numerous international oncology journals and has served as guest editor for several leading oncology publications. He is also involved in the Global Burden of Disease (GBD) research network, contributing to large-scale analyses that inform cancer epidemiology and health policy worldwide, and is a regular contributor to the American Society of Clinical Oncology (ASCO) Connection platform, where he shares insights on oncology practice, system development, and global cancer care. He also chairs sessions at major international congresses (e.g., ESMO Congress 2025). His areas of expertise include precision oncology and cancer care in the UAE. In 2016, he co-authored with his MD Anderson colleagues a landmark study in the Journal of Clinical Oncology that described a new distinct subgroup of colorectal cancer: non-V600 BRAF-mutated colorectal cancer. In 2022, Professor Al-Shamsi published the first book on cancer research in the UAE and the first book on cancer in the Arab world, both launched at Dubai Expo 2020. Cancer in the Arab World has been downloaded more than 600,000 times in its first two years and remains the ultimate source of cancer data in the Arab region. He also published the first comprehensive book Cancer Care in the United Arab Emirates , the first book in UAE history to document cancer care in the country, addressing many topics for the first time. In addition, he authored the open-access book Healthcare in the United Arab Emirates . This book achieved over 100,000 downloads in its first two months. All of his books have been made open access to ensure free access to scientific knowledge for everyone. His cancer research focuses on precision oncology and multi-omics AI-driven biomarker discovery in cancer.

Professor Al-Shamsi is passionate about advancing cancer care across the UAE and the GCC region. As President of the Emirates Oncology Society and through his leadership role in the Gulf Cancer Society, he has helped build one of the most active oncology education platforms in the MENA region, offering frequent, high-quality educational activities accessible to oncologists across the region. He has been instrumental in bringing major international oncology educational initiatives to the UAE and the MENA region, including Best of ESMO, ESMO Breast, and Best of ASCO. He has made significant contributions to cancer awareness and early detection through public education on social media platforms and has championed free consultations for cancer patients without insurance, ensuring no patient is denied timely expert guidance due to financial barriers. He is recognized as the most followed oncologist in the world, with over one million subscribers across Instagram, Twitter (X), LinkedIn, and TikTok. In 2022, he received the prestigious Feigenbaum Leadership Excellence Award from Sheikh Hamdan Smart University for his exceptional leadership and research contributions. He was also awarded the Sharjah Award for Volunteering in recognition of providing thousands of free consultations to cancer patients across the UAE and the MENA region. He was named Researcher of the Year in the UAE in both 2020 and 2021 by the Emirates Oncology Society.

In May 2024, His Highness Sheikh Mansour bin Zayed Al Nahyan, Vice President of the United Arab Emirates, awarded him first place in the Emirati Talent Competitiveness Council (NAFIS) program for outstanding leadership in the private sector across all business and medical disciplines. He was recognized as one of The 100 Most Influential CEOs in Oncology in 2025. In February 2025, he was awarded the Sheikha Fatima bint Mubarak Program for Excellence and Community Intelligence Award by the UAE President in recognition of his role as a successful role model in UAE society for increasing cancer awareness across the UAE and GCC. In October 2025, he was officially received by His Highness Sheikh Mohamed bin Zayed Al Nahyan, President of the UAE, in recognition of his academic achievements (Harvard Visiting Professor and Dana-Farber appointments) as the first GCC national to achieve this academic ranking. As CEO of Burjeel Cancer Institute, Professor Al-Shamsi leads the largest cancer network in the UAE, comprising more than 30 oncologists and hematologists. Despite his extensive leadership, academic, and administrative responsibilities, he remains in full clinical practice, conducting clinics five days a week to continue providing direct, high-quality care to his patients.

Under his leadership, the institute has built one of the country’s first comprehensive adult and pediatric bone marrow transplant programs and secured the UAE’s first European Society for Medical Oncology (ESMO) accreditation for a cancer center. In addition to his clinical and administrative responsibilities, he is actively engaged in education and research training for medical trainees at all levels to enhance their clinical and research skills. He has shaped the future oncology workforce of the UAE by establishing the country’s first hematology and oncology fellowship training pathway and currently serves as Chairman of the Hematology and Oncology Fellowship Program, accredited by the UAE National Institute for Health Specialties at Burjeel Cancer Institute. Professor Al-Shamsi’s leadership has profoundly shaped the UAE oncology landscape. He has been a key architect behind several landmark national initiatives that have transformed cancer care delivery in the country. These include major contributions to the development of advanced national oncology care standards in collaboration with health authorities, the launch of the UAE’s National Guideline for Lung Cancer Screening and Diagnosis—which established a unified, evidence-based framework for early detection and risk stratification—and the establishment of the National Multidisciplinary Committee for Cancer Case Assessment through Ministerial Decree No. (20) of 2025, which formalizes multidisciplinary decision-making at a national level. In addition, he holds governmental advisory roles, including Advisor and Member of Governmental Committees for the Department of Health – Abu Dhabi, Dubai Health Authority, Ministry of Health & Prevention, and has been a Member of the Steering Committee on National Cancer Control Indicators since January 2018. His mission is to advance cancer care in the UAE and the MENA region and to make high-quality cancer care accessible to everyone in need around the globe.

Professional Profile.

The Dr. Pat Kennedy Award Apr 2026 The inaugural Dr. Pat Kennedy Award was presented in April 2026 in recognition of Prof. Humaid Al-Shamsi’s outstanding contributions to advancing cancer care.
Sheikha Fatima bint Mubarak Program for Excellence and Community Intelligence Award (7th Cycle) Feb 2025 Category: Honorary Family Category Awarded by His Highness Sheikh Mohamed bin Zayed Al Nahyan, President of the UAE, in recognition of outstanding contributions to community leadership and social impact, particularly in the role as President of the Emirates Oncology Society and CEO of Burjeel Cancer Institute. https://www.wam.ae/en/article/bieay6y-uae-president-confers-%E2%80%98order-the-mother-the
UAE President Receives Professor Humaid Al Shamsi 2025 https://www.nmo.gov.ae/en/news/uae-president-receives-professor-humaid-al-shamsi
NAFIS Award May 2024 Awarded first place by HH Sheikh Mansour bin Zayed Al Nahyan, Vice President of the UAE, for outstanding leadership in the private sector across business and medical disciplines. https://gulfnews.com/business/corporate-news/burjeel-holdings-excels-at-nafis-award-secures-three-first-places-for-emirati-talent-development-1.1715695805906
Feigenbaum Leadership Excellence Award – Accomplished Leaders Category Sheikh Hamdan Bin Mohammed Smart University Mar 2022 Awarded in recognition of exemplary leadership and contributions to organizational excellence and quality-driven culture in the Arab world.
Sharjah Award for Voluntary Work May 2022 Recognized for cancer awareness efforts in the UAE and the region.
UAE Genetic Diseases Association (UAEGDA) Distinguished Clinical Award May 2022 Awarded for contributions to advancing cancer care in the UAE, including the establishment of a bone marrow transplantation unit. https://twitter.com/NET_AD/status/1530124525769203712
First Graduate – Sheikh Khalifa bin Zayed Distinguished Physician Training Program 2016 https://www.albayan.ae/across-the-uae/news-and-reports/2018-02-12-1.3184386
The Oncologist Journal Jul 2020 Awarded by Editor-in-Chief Bruce A. Chabner (Massachusetts General Hospital, Harvard Medical School) for the publication: “A Practical Approach to the Management of Cancer Patients During the COVID-19 Pandemic: An International Collaborative Group.” https://theoncologist.onlinelibrary.wiley.com/journal/1549490x/homepage/anniversaryretrospective
Outstanding Researcher of the Year Emirates Medical Association Sep 2020 Recognized for publishing over 10 research papers in high-impact journals.
Researcher of the Year Emirates Medical Association Sep 2021 Recognized for publishing over 20 research papers. https://eos-uae.com/2nd-eos-annual-conference/
EOS Cancer Awareness Advocate of the Year 2021 https://eos-uae.com/2nd-eos-annual-conference/
Certificate of Appreciation UAE Embassy, Washington, D.C., USA 2012 Awarded for excellence in clinical and research performance during fellowship training at McMaster University.
MSA (Medical Staff Association) Outstanding Senior Resident of the Year Award McMaster University, Canada 2012 Nominated by the Medical Oncology Department; one of three awards across Hamilton Health Sciences among approximately 150 trainees.
Jeff Ginsberg Subspecialty Resident Award McMaster University, Canada 2012 Nominated by the Medical Oncology Program Director; one award across all Internal Medicine subspecialties.
Runner-Up – Chief Resident of the Year Internal Medicine Training Program 2009 – 2010 Recognized for excellence in medical education and administrative leadership during chief residency at Hamilton General Hospital (Jan 2010 – Mar 2010).
Internal Medicine Chief’s Cup 2009 – 2010 Member of the Hamilton General Hospital Internal Medicine Chief’s Team.
Certificate of Appreciation UAE Embassy, London, UK 2004 Awarded for achieving honors in Bachelor of Medicine and Surgery at University College Cork.
Stuart Jay Cohen Memorial Award – 1st Place Student Research Day, Department of Oncology, McMaster University 2012
Clinical Research – Poster Presentation: Venous thromboembolism events in patients with colorectal cancer treated with FOLFIRI plus bevacizumab – Juravinski Cancer Centre experience (Supervisor: Dr. P. Major).
Stuart Jay Cohen Memorial Award – 2nd Place Student Research Day, Department of Oncology, McMaster University 2012
Clinical Research – Oral Presentation: “The current practice of screening, prevention, and treatment of androgen deprivation therapy-induced osteoporosis in patients with prostate cancer” (Supervisor: Dr. Alexandra Papaioannou).

Al-Shamsi, Humaid O. "Healthcare in the United Arab Emirates" https://link.springer.com/book/10.1007/978-981-96-0523-1
Al-Shamsi, Humaid O. "Cancer Care in the United Arab Emirates" https://link.springer.com/book/10.1007/978-981-99-6794-0
Al-Shamsi, Humaid O., Ibrahim H. Abu-Gheida, Faryal Iqbal, and Aydah Al-Awadhi. "Cancer in the Arab World." The book has been downloaded more than 500,000 times within the first two years of publication. https://link.springer.com/book/10.1007/978-981-16-7945-2
Al-Shamsi, H.O., & Iqbal, F. (2025). History of healthcare in the UAE. In Healthcare in the United Arab Emirates (pp. 1–32). Singapore: Springer Nature Singapore. https://link.springer.com/chapter/10.1007/978-981-96-0523-1_1
Al-Shamsi, H.O., Al Dhaheri, A., Shersad, F., & Al-Houqani, M. (2025). National Institute for Health Specialties (NIHS) in the UAE. In Healthcare in the United Arab Emirates (pp. 111–122). Singapore: Springer Nature Singapore. https://link.springer.com/chapter/10.1007/978-981-96-0523-1_8
Ganesan, S., Al-Shamsi, H.O., Mostafa, M., & Zaher, W.A. (2025). Research productivity of health sciences institutions in the UAE: A 20-year bibliometric analysis. In Healthcare in the United Arab Emirates (pp. 201–215). Singapore: Springer Nature Singapore. https://link.springer.com/chapter/10.1007/978-981-96-0523-1_15
Al-Shamsi, H.O., & Iqbal, F. (2025). Cancer care in the UAE. In H.O. Al-Shamsi (Ed.), Healthcare in the United Arab Emirates. Singapore: Springer. https://doi.org/10.1007/978-981-96-0523-1_26
Nijhawan, N.A., Al-Shamsi, H.O., & Ibrahim, H. (2025). Palliative and hospice medicine in the UAE. In Healthcare in the United Arab Emirates (pp. 413–429). Singapore: Springer Nature Singapore. https://link.springer.com/chapter/10.1007/978-981-96-0523-1_27
Al-Shamsi, H.O., Thwaini, A., Iqbal, F., Darwish, O., Rao, A., Janahi, F., Rahman, A.A., Al-Qudah, H., & Al Kasab, T. (2025). Urology in the UAE. In Healthcare in the United Arab Emirates (pp. 521–543). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-96-0523-1_34
Mendonca, V., & Al-Shamsi, H.O. (2025). The future of healthcare in the UAE. In Healthcare in the United Arab Emirates (pp. 841–848). Singapore: Springer Nature Singapore. https://link.springer.com/chapter/10.1007/978-981-96-0523-1_52
Al-Shamsi, H.O. (2024). Introduction. In H.O. Al-Shamsi (Ed.), Cancer Care in the United Arab Emirates. Singapore: Springer. https://doi.org/10.1007/978-981-99-6794-0_1
Al-Shamsi, H.O., & Abyad, A.M. (2024). Cancer care in the UAE. In Cancer Care in the United Arab Emirates (pp. 15–56). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_2
Rafii, S., & Al-Shamsi, H.O. (2024). Cancer prevention, screening, and early detection in the UAE. In Cancer Care in the United Arab Emirates (pp. 79–90). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_4
Al-Shamsi, H.O., & Abyad, A.M. (2024). A proposal for a cancer control plan in the UAE. In Cancer Care in the United Arab Emirates (pp. 91–126). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_5
Al-Shamsi, H.O., & Abyad, A.M. (2024). Comprehensive cancer centers in the UAE. In Cancer Care in the United Arab Emirates (pp. 127–135). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_6
Al-Shamsi, H.O., & Abyad, A.M. (2024). Emirates Oncology Society. In Cancer Care in the United Arab Emirates (pp. 137–151). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_7
Al-Shamsi, H.O. (2024). Factors influencing seeking cancer care abroad for UAE citizens. In Cancer Care in the United Arab Emirates (pp. 153–161). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_8
Ganesan, S., Al-Shamsi, H.O., Mostafa, M., & Zaher, W.A. (2024). Clinical cancer research in the UAE. In Cancer Care in the United Arab Emirates (pp. 175–192). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_10
Al-Shamsi, H.O. (2024). Oncology and hematology fellowship training in the UAE. In Cancer Care in the United Arab Emirates (pp. 209–214). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_12
Nijhawan, N.A., & Al-Shamsi, H.O. (2024). Palliative care in the UAE. In Cancer Care in the United Arab Emirates (pp. 359–376). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_22
Al-Awadhi, A., Iqbal, F., Kourie, H.R., & Al-Shamsi, H.O. (2024). Breast cancer in the UAE. In Cancer Care in the United Arab Emirates (pp. 417–434). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_26
Al-Shamsi, H.O., Iqbal, F., Kourie, H.R., Al Zaabi, A.A., Abyad, A.M., & Abdelwahed, N. (2024). Colorectal cancer in the UAE. In Cancer Care in the United Arab Emirates (pp. 435–450). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_27
Abdelwahed, N., Al Asousi, S., Iqbal, F., Abyad, A.M., Nijhawan, N.A., Kourie, H.R., Abu-Gheida, I.H., Ammori, B., & Al-Shamsi, H.O. (2024). Gastric cancer in the UAE. In Cancer Care in the United Arab Emirates (pp. 451–472). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_28
Al-Shamsi, H.O., Iqbal, F., Nijhawan, N.A., Kourie, H.R., Abdelwahed, N., Abu-Gheida, I.H., & Ammori, B. (2024). Pancreatic cancer in the UAE. In Cancer Care in the United Arab Emirates (pp. 473–489). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_29
Bendardaf, R., Talaat, I.M., Elemam, N.M., & Al-Shamsi, H.O. (2024). Thyroid cancer in the UAE. In Cancer Care in the United Arab Emirates (pp. 545–557). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_32
Rafii, S., Aboud, B., & Al-Shamsi, H.O. (2024). Lung cancer in the UAE. In Cancer Care in the United Arab Emirates (pp. 559–568). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_33
Sawan, S., Iqbal, F., & Al-Shamsi, H.O. (2024). Gynecologic malignancies in the UAE. In Cancer Care in the United Arab Emirates (pp. 569–580). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_34
Shahait, M., Al-Qudah, H., Mula-Hussain, L., Abu-Gheida, I.H., Alkasab, T., Thwaini, A., Madi, R., Al-Shamsi, H.O., Tirmazy, S.H., & Mukherji, D. (2024). Genitourinary malignancies in the UAE. In Cancer Care in the United Arab Emirates (pp. 581–592). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_35
Al-Awadhi, A., & Al-Shamsi, H.O. (2024). Neuroendocrine tumors (NETs) in the UAE. In Cancer Care in the United Arab Emirates (pp. 597–601). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_37
Al-Shamsi, H.O., Abyad, A.M., Kanakande Kandy, Z.A., George, B., Dar-Yahya, M., Kaloyannidis, P., El-Saddik, A., Rana, S., & Khalil, C. (2024). Hematopoietic stem cell transplantation (HSCT) in the UAE. In Cancer Care in the United Arab Emirates (pp. 611–624). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_39
Al-Shamsi, H.O. (2024). Suggested quality control measures for cancer care in the UAE. In Cancer Care in the United Arab Emirates (pp. 629–637). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_41
Abu-Gheida, I.H., Nijhawan, N.A., Al-Awadhi, A., & Al-Shamsi, H.O. (2022). General oncology care in the UAE. In Cancer in the Arab World (pp. 301–319). Singapore: Springer. https://doi.org/10.1007/978-981-16-7945-2_19
Al-Shamsi, H.O., & Iqbal, F. (2022). General oncology care in Qatar, Comoros, and Djibouti. In Cancer in the Arab World (pp. 339–352). Singapore: Springer. https://doi.org/10.1007/978-981-16-7945-2_21
Al-Shamsi, H.O., Iqbal, F., & Abu-Gheida, I.H. (2022). Introduction. In Cancer in the Arab World. Singapore: Springer. https://doi.org/10.1007/978-981-16-7945-2_1
Nijhawan, N.A., & Al-Shamsi, H.O. (2021). Palliative care in the United Arab Emirates. In Handbook of Healthcare in the Arab World (pp. 2315–2332). Cham: Springer International Publishing. https://doi.org/10.1007/978-3-319-74365-3_102-1
Abu-Gheida, I.H., Nijhawan, N.A., & Al-Shamsi, H.O. (2021). Oncology care in the UAE. In Handbook of Healthcare in the Arab World (pp. 521–538). Cham: Springer International Publishing. https://doi.org/10.1007/978-3-319-74365-3_183-1
Al-Shamsi, H., Hansel, D.E., Bellmunt, J., & Siefker-Radtke, A.O. (2017). Uncommon cancers of the bladder. In Textbook of Uncommon Cancer. https://doi.org/10.1002/9781119196235.ch5
Al-Shamsi, H., Siefker-Radtke, A.O., Czerniak, B., Dinney, C., & Millikan, R.E. (2016). Uncommon cancers of the bladder. In Textbook of Uncommon Cancer (5th ed.). John Wiley & Sons.
Jarrah, M.M., Al‐Shamsi, H.O., Abuhelwa, Z., Bustanji, Y., Semreen, M.H., McKinnon, R.A., Sorich, M.J., Hopkins, A.M. and Abuhelwa, A.Y., 2026. Treatment‐Specific Prediction Models in Multiple Myeloma: A Critical Review of Current Evidence and Future Directions. European Journal of Haematology. https://onlinelibrary.wiley.com/doi/full/10.1111/ejh.70177
Abuhelwa, A.Y., Almansour, S.A., Al-Shamsi, H.O., Abuhelwa, Z., Alqudah, M.A., Bustanji, Y., Semreen, M.H., Alzoubi, K.H., Modi, N.D., McKinnon, R.A. and Sorich, M.J., 2026. Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trials. Scientific Reports. https://doi.org/10.1038/s41598-026-37464-4
Moshi, J.M., Abdelwahab, S.I., Taha, M.M.E., Alamer, D.A., Maashi, H.M., Badri, R.M., Jeraiby, M., Maashi, S.M., Majrashi, E.J.M., Bajawi, Y.A. and Al‐Shamsi, H.O., 2026. Breast Cancer Awareness and Screening Predictors in Young Saudi Women: Findings From a Cross‐Sectional Study. Health Science Reports, 9(3), p.e71831. https://doi.org/10.1002/hsr2.71831
Abuhelwa, A.Y., Almansour, S.A., Al-Shamsi, H.O., Abuhelwa, Z., Ziade, M.A., McKinnon, R.A., Sorich, M.J. and Hopkins, A.M., 2026. HSR26-204: Baseline EORTC QLQ-C30 “Clinically Important” Symptom Burden Predicts Survival and Toxicity in CLL/SLL Across Randomized Ibrutinib Trials. Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7459
Abdelwahab, S.I., Taha, M.M.E., Farasani, A., Abdullah, S.M., Alshahrani, S., Assiri, A., Moshi, J.M., Khamjan, N.A., Al-Shamsi, H., Alshahrani, A.F. and Mohan, S., 2026. Emerging Trends and Conceptual Mapping in Network Pharmacology Research: A Bibliometric Analysis (2008-2023) Using VOSviewer. Ind. J. Pharm. Edu. Res, 60(2s), pp.s651-s662. DOI: 10.5530/ijper.20262593. https://nchr.elsevierpure.com/en/publications/emerging-trends-and-conceptual-mapping-in-network-pharmacology-re/
Al-Shamsi, H.O., Rasul Snr, K., Shablak, A., ALnajjar, A., Shabaan, A.M.A., Al Sindi, M., Nasr, M., AlJabban, A. and Rafii, S., 2025. Diagnosis and Management of Colorectal Cancer in the Gulf Area: Current Practice and Future Suggestions from Expert Opinions. OncoTargets and Therapy, pp.1265-1279. https://doi.org/10.2147/ott.s535858
Latif, M.F., Tirmazy, S.H., Hamza, D.M., Das, K., Omara, M., Basit, A., Saber, N. and Al-Shamsi, H.O., 2025. 59eP Correlation between Oncotype Dx recurrence score and clinicopathological factors in early breast cancer: A retrospective single institution study, Dubai Hospital, Dubai, UAE. Annals of Oncology, 36, p.S1784. https://doi.org/10.1016/j.annonc.2025.10.893
Rafii, S., Mukherji, D., Komaranchath, A.S., Khalil, C., Iqbal, F., Abdelwahab, S.I., Abyad, A., Abuhelwa, A.Y., Gandikota, L. and Al-Shamsi, H.O., 2025. Advancing CAR T-cell therapy in solid tumors: current landscape and future directions. Cancers, 17(17), p.2898. https://doi.org/10.3390/cancers17172898
Syrigos, K.N., Bussell, M.E., Al-Shamsi, H.O., Khorshid, O., Herbst, R.S., Agelaki, S., Leighl, N., Hirsch, F. and Wakelee, H., 2025. Bridging the gap in lung cancer: A comprehensive global strategy for change. European Journal of Cancer, p.116069. https://doi.org/10.1016/j.ejca.2025.116069
Moshi, J.M., Abdelwahab, S.I., Taha, M.M.E., Albasheer, O., Abdullah, S.M., Farasani, A., Jeraiby, M.A., Al-Shamsi, H.O., Hakami, A.M.S., Khamjan, N.A. and Alshahrani, S., 2025. Cancer research in Saudi Arabia: A cross-sectional mapping study of historical growth, thematic analysis, collaboration patterns, and future directions. Medicine, 104(39), p.e44757. DOI: 10.1097/MD.0000000000044757. https://journals.lww.com/md-journal/fulltext/2025/09260/cancer_research_in_saudi_arabia__a_cross_sectional.36.aspx
Mukherji, D., Agarwal, M., Al-Shamsi, H.O., Angel, M., Da Rosa, D.A.R., Limaye, S., Talreja, V., El Morsi, W., Ürün, Y. and Grande, E., 2026. Social media for healthcare professionals in oncology: results from a cross-sectional survey conducted across eight countries in Asia, Latin America, and the Middle East. Future Oncology, 22(2), pp.203-216. https://doi.org/10.1080/14796694.2025.2548192
Kandy, Z.A.K., Nivargi, S., Chaudhary, B., Ramzan, M., Abdullah, F., Aboobacker, F., Khalil, C., Porta, F., Faulkner, L. and Alshamsi, H., 2025. Outcomes of hematopoietic stem cell transplantation (HSCT) from matched related donors in pediatric patients: insights from a single center in the United Arab Emirates. Cureus, 17(8). DOI: 10.7759/cureus.89239. https://www.cureus.com/articles/372874#!/
Jagadeesan, S., Kalyanasundaram, K., Alghamdi, M., Mohammed, M., Sweidan, R., Abdalqader, A., Sonawane, Y., Al-Shamsi, H. and Abu-Gheida, I., 2025. Feasibility of a robust and homogeneous volumetric modulated arc therapy based total body irradiation technique and analysis of dose rate using Elekta solutions. Medical Dosimetry. https://doi.org/10.1016/j.meddos.2025.06.003
Shehab, A., Al Dhanhani, H., Alhammadi, O., Hassan, M.B., Farghaly, M., Hassoun, A., Mahboub, B., Tahlak, M., Abutayeh, R.F., Haridy, H., Hassanien, A., Joury J., Al-Shamsi, H. O. 2025. Strategies for the Prevention and Management of Respiratory Infections in Patients at High Risk in the UAE: A Cross-Disciplinary Position Paper. Pulmonary Therapy, 11(3), pp.405-421. https://doi.org/10.1007/s41030-025-00304-3
Abdelwahab, S.I., Moni, S.S., Taha, M.M.E., Sahli, K.A., Alqhtani, H.A.S., Farasani, M.M., Qadri, M., Alarifi, A., Khardali, A., Alsaadi, K.H., Farasani, A., Khamjan A. Nizar., Al-Shamsi, H. O. et al. 2025. Mapping breast cancer research on monoclonal antibodies: a data-driven approach using VOSviewer, Bibliometrix, and CiteSpace. Naunyn-Schmiedeberg's Archives of Pharmacology, pp.1-21. https://doi.org/10.1007/s00210-025-04401-7
Mukherji, D., Fadhil, I., Faraj, W., Rafii, S. and Al-Shamsi, H.O., 2025. Cancer control in the United Arab Emirates. The Lancet Oncology. https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00077-4/abstract
Shreenivas AV, Cristofanilli M, Limaye SA, Gaya AM, Crook T, Ajami R, Mokbel K, Schaffrin-Nabe D, Al-Shamsi H.O., Mandal TK, Shingla S. Molecular profiling of body fluid cfDNA: Advancing diagnostics and therapeutic decisions. https://doi.org/10.1200/JCO.2025.43.16_suppl.3054
Patil, D., Grewal, U.S., Vaid, A.K., Advani, S.H., Shingla, S., Varshney, A.N., Gaya, A.M., Al-Shamsi, H.O., Wilson, J., Mandal, T.K. and Crook, T., 2025. Molecular diversity in neuroendocrine tumors: A house divided. https://ascopubs.org/doi/pdf/10.1200/JCO.2025.43.16_suppl.e15170
Abuhelwa, A.Y., Almansour, S.A., Basch, E., Al‐Shamsi, H.O., Abuhelwa, Z., Bustanji, Y., Semreen, M.H., Kharaba, Z., Ali, S.M., Mohamed, R. and Kichenadasse, G., 2025. Predictive and Prognostic Significance of Patient‐Reported Outcomes for Survival and Adverse Events in Daratumumab‐Treated Multiple Myeloma. European Journal of Haematology, 114(6), pp.1020-1031. https://doi.org/10.1111/ejh.14410
Abdelwahab, S.I., Taha, M.M.E., Sahli, K.A., Alqhtani, H.A.S., Farasani, A., Khamjan, N.A., Al-Shamsi, H., Moshi, J.M., Alshahrani, S., Assiri, A. and Qadri, M., 2025. Graphene-based biosensors for PSA. Clinica Chimica Acta, 576, p.120406. https://doi.org/10.1016/j.cca.2025.120406
Abuhelwa, A.Y., Almansour, S.A., Brown, J.R., Al-Shamsi, H.O., Abuhelwa, Z., Kharaba, Z., Bustanji, Y., Semreen, M.H., Ali, S., Alhuraiji, A. and McKinnon, R.A., 2025. Statin use and survival in CLL/SLL treated with ibrutinib: pooled analysis of 4 randomized controlled trials. Blood advances, 9(14), pp.3566-3575. https://doi.org/10.1182/bloodadvances.2024015287
El-Deiry W.S., Bresson C., Wunder F., Carneiro B.A., Dizon D.S., Warner J.L., Graff S.L., Azzoli C.G., Wong E.T., Cheng L., Mani S.A., Safran H.P., Williams C., Meissner T., Solomon B., Rubin E., Porgador A., Berchem G., Saintigny P., Onn A., Bar J., Berger R., Gantenbein M., Chen Z., Souza C.P., Reis R.M.V., Sekacheva M., Cervantes A., Dahut W.L., Annunziata C.M., Gober K., Musallam KM., Al-Shamsi H.O., Abu-Gheida I., Salazar R., et. Al. 2025. Worldwide innovative network (WIN) consortium in personalized cancer medicine: bringing next-generation precision oncology to patients. Oncotarget, 16, p.140. https://doi.org/10.18632/oncotarget.28703
Al-Shamsi, H.O., Abdelwahed, N. and Mokbel, K., 2025. Surveillance Systemic Imaging After Curative Intent for Breast Cancer: A Double Standard?. Journal of Clinical Oncology, 43(1), pp.109-111. https://doi.org/10.1200/JCO.24.01186
Nijhawan, N.A., Al-Shamsi, H., Sweeting, K., Mustafa, R., Sheikh, A., Khan, J.K., Tareen, M., Safi, A.M. and Hami, F., 2025. Palliative care in United Arab Emirates: Response to The Lancet Commission on the value of death. Eastern Mediterranean Health Journal, 31(12), pp.666-668. https://doi.org/10.26719/2025.31.12.666
Al-Shamsi, H.O., Oner, M. and Mokbel, K., 2025. Balancing evidence and individualization in adjuvant CDK4/6 therapy. Translational Cancer Research, 14(8), pp.4479-4481. https://doi.org/10.21037/tcr-2025-879
Al-Shamsi, H.O., Patil, D.S., Limaye, S., Vaid, A.K., Datar, R., Fuller-Shavel, N., Lechner, M., Krupashankar, S., Shah, D.K., Shingla, S. and Datta, A., 2025. 151P Exosomal miRNA-based classification of breast cancer subtypes in patients unsuitable for tissue biopsy. Annals of Oncology, 36, p.S266. https://doi.org/10.1016/j.annonc.2025.08.585
Limaye, S., Datar, R., Syed, N., Ghaisas, A., Akolkar, D., Chougule, R., ... & Al-Shamsi, H. O. 2025. 1747P Real-world performance of an AI-driven U-Net-Based pipeline for automated detection of circulating tumor cells (CTCs) in a screening population. Annals of Oncology, 36, p.S1025. https://doi.org/10.1016/j.annonc.2025.08.2376
Kaloyannidis, P., George, B., Alrustamani, A., Khalil, C., Al-Charfli, B., Al-Moghrabi, N., ... & Al-Shamsi, H.O. 2024. Paving the Road for Haematopoietic Stem Cell Transplantation in the United Arab Emirates: A Single Centre’s Experience. Journal of Blood Medicine, pp.471-475. https://doi.org/10.2147/jbm.s468665
Albaldawy, M.J., Ebaied, T., Al Shamsi, H.O., Nadaf, A., Abbu, R.U.F. and Al Shamsi, H.O., 2024. Adult-Onset Pediatric-Type Follicular Lymphoma of the Parotid Gland. Cureus, 16(12). https://doi.org/10.7759/cureus.76161
Abusanad, A., Alawadi, A., Mukharji, D., Abualkair, O., Almansoori, N., Alsindi, M. and Al-Shamsi, H.O., 2024. Insights and solutions for advancing and empowering women in oncology from the Gulf Cooperation Council Countries. ESMO open, 9(10), p.103723. https://doi.org/10.1016/j.esmoop.2024.103723
Almansour, S.A., Alqudah, M.A., Abuhelwa, Z., Al-Shamsi, H.O., Alhuraiji, A., Semreen, M.H., Bustanji, Y., Alzoubi, K.H., Modi, N.D., Mckinnon, R.A. and Sorich, M.J., 2024. Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials. Therapeutic Advances in Medical Oncology, 16, p.17588359241275387. https://doi.org/10.1177/17588359241275387
Al‐Shamsi, H.O. and Musallam, K.M., 2024. Not only a Western world issue: Cancer incidence in younger individuals in the United Arab Emirates. CA: A Cancer Journal for Clinicians, 74(3). https://doi.org/10.3322/caac.21839
Al-Shamsi, H.O., Abdelwahab, S.I., Albasheer, O., Taha, M.M.E., Alqassim, A.Y., Alharbi, A., Farasani, A., Altraifi, A.A.A., Medani, I.E., Hakami, N. and Abdelmola, A.O., 2024. Cancer research in the United Arab Emirates from birth to present: A bibliometric analysis. Heliyon, 10(6). https://doi.org/10.1016/j.heliyon.2024.e27201
Allehebi, A., Al-Omair, A., Mahboub, B., Koegelenberg, C.F., Mokhtar, M., Madkour, A.M., Al-Asad, K., Selek, U. and Al-Shamsi, H.O., 2024. Recommended approaches for screening and early detection of lung cancer in the Middle East and Africa (MEA) region: a consensus statement. Journal of Thoracic Disease, 16(3), pp.2142-2158. https://pmc.ncbi.nlm.nih.gov/articles/PMC11009596/
Laguna, J.C., Garcia-Pardo, M., Alessi, J., Barrios, C., Singh, N., Al-Shamsi, H.O., Loong, H., Ferriol, M., Recondo, G. and Mezquita, L., 2024. Geographic differences in lung cancer: focus on carcinogens, genetic predisposition, and molecular epidemiology. Therapeutic advances in medical oncology, 16, p.17588359241231260. https://doi.org/10.1177/17588359241231260
Almansour, S.A., Alqudah, M.A., Abuhelwa, Z., Al-Shamsi, H.O., Semreen, M.H., Bustanji, Y., Soare, N.C., McKinnon, R.A., Sorich, M.J., Hopkins, A.M. and Abuhelwa, A.Y., 2024. Association of proton pump inhibitor use with survival and adverse effects outcomes in patients with multiple myeloma: pooled analysis of three clinical trials. Scientific Reports, 14(1), p.591. https://doi.org/10.1038/s41598-023-48640-1
Al-Shamsi, H.O., Abdelwahed, N., Abyad, A., Abu-Gheida, I., Afrit, M., Abu ElFuol, T., Alasas, R., Lababidi, B., Dash, P., Ahmad, M., Dreier, N.W., et al. 2023. Breast cancer in the Arabian Gulf countries. Cancers, 15(22), p.5398. https://doi.org/10.3390/cancers15225398
Abbas, N.F., Aoude, M.R., Kourie, H.R. and Al-Shamsi, H.O., 2024. Uncovering the epidemiology of bladder cancer in the Arab world: A review of risk factors, molecular mechanisms, and clinical features. Asian Journal of Urology, 11(3), pp.406-422. https://doi.org/10.1016/j.ajur.2023.10.001
Al-Shamsi, H.O., Abdelwahed, N., Singh, M., Abyad, A.M., Elsabae, S., Abdelgawad, T., Iqbal, F., Ibrahim, N. 2023. First reported case of successful conception and delivery during stage IV breast cancer treatment: A case report and literature review. Cureus, 15(10). https://doi.org/10.7759/cureus.47201
Al-Shamsi, H.O., Abu-Gheida, I., Sameh, K., Tahoun, N.E. and Musallam, K.M., 2023. Arab countries and oncology clinical trials: A bibliometric analysis. Cancers, 15(18), p.4428. https://doi.org/10.3390/cancers15184428
Elkaddoum, R., Zakhour, J., Hajal, M., Aoun, M., Njeim, M., Mahrous, M., Al-Shamsi, H.O., Brahim, Z.B., Khatib, S.A. and Kourie, H.R., 2023. Improving the management of ALK-rearranged non-small-cell lung cancer through a mobile application: a physicians-based survey. Pharmacogenomics, 24(13), pp.725-730. https://pubmed.ncbi.nlm.nih.gov/37706248/
Kourie, H.R., Mahrous, M., Naim, N., Zouein, J., Benbrahim, Z., Rasul, K., Mokhtar, M., Shehri, A.A., Shakeeb, M., Khatib, S. and Al-Shamsi, H., 2023. The first Middle East and North Africa expert consensus recommendations for management of advanced gastric cancer. https://pubmed.ncbi.nlm.nih.gov/37526151/
Humaid Al-Shamsi, S., Humaid Al-Shamsi, A., Humaid Al-Shamsi, M., Sajwani, A., Alzaabi, M.S., Al Hammadi, O., Iqbal, F. and Al-Shamsi, H.O., 2023. The perception and awareness of the public about cancer and cancer screening in the United Arab Emirates, a population-based survey. Clinics and Practice, 13(3), pp.701-714. https://doi.org/10.3390/clinpract13030064
Bernstein, E., Lev-Ari, S., Shapira, S., Leshno, A., Sommer, U., Al-Shamsi, H., Shaked, M., Segal, O., Galazan, L., Hay-Levy, M., Sror, M., et al. 2023. Data from a one-stop-shop comprehensive cancer screening center. Journal of Clinical Oncology, 41(14), pp.2503-2510. https://doi.org/10.1200/JCO.22.00938
Albarrak, J. and Al-Shamsi, H., 2023. Current status of management of hepatocellular carcinoma in the Gulf region: challenges and recommendations. Cancers, 15(7), p.2001. https://doi.org/10.3390/cancers15072001
Abboud, K., Umoru, G., Esmail, A., Abudayyeh, A., Murakami, N., Al-Shamsi, H.O., Javle, M., Saharia, A., Connor, A.A., Kodali, S., Ghobrial, R.M., and Abdelrahim M. 2023. Immune checkpoint inhibitors for solid tumors in the adjuvant setting: current progress, future directions, and role in transplant oncology. Cancers, 15(5), p.1433. https://doi.org/10.3390/cancers15051433
Park, S.H., Hong, S.H., Kim, K., Lee, S.W., Yon, D.K., Jung, S.J., Abdeen, Z., Ghayda, R.A., Ahmed, M.L.C.B., Serouri, A.A., Al‐Herz, W., Al-Shamsi, H.O., Ali, S., et al. 2023. Nonpharmaceutical interventions reduce the incidence and mortality of COVID‐19: A study based on the survey from the International COVID‐19 Research Network (ICRN). Journal of Medical Virology, 95(2), p.e28354. https://doi.org/10.1002/jmv.28354
Halaseh, S.A., Al-Karadsheh, A., Mukherji, D., Alhjahaja, A., Farkouh, A.A., Al-Ibraheem, A., Gheida, I.A., Al-Khateeb, S., Al-Shamsi, H. and Shahait, M., 2023. Prostate cancer clinical trials in low-and middle-income countries. ecancermedicalscience, 17, p.1629. https://doi.org/10.3332/ecancer.2023.1629
Baqain, L., Mukherji, D., Al-Shamsi, H.O., Abu-Gheida, I., Al Ibraheem, A., Al Rabii, K., Farkouh, A.A. and Shahait, M., 2023. Quality and reliability of YouTube videos in Arabic as a source of patient information on prostate cancer. ecancermedicalscience, 17, p.1573. https://pmc.ncbi.nlm.nih.gov/articles/PMC10393303/
Al-Shamsi, H.O., Abdelwahed, N., Al-Awadhi, A., Albashir, M., Abyad, A.M., Rafii, S., Afrit, M., Al Lababidi, B., Abu-Gheida, I., Sonawane, Y.P., Nijhawan, N.A.,et al. 2023. Breast cancer in the United Arab Emirates. JCO Global Oncology, 9, p.e2200247. https://doi.org/10.1200/GO.22.00247
Nijhawan, N.A. and Al-Shamsi, H.O., 2022. Experiences and challenges of a new palliative care service in the United Arab Emirates. Palliative Medicine and Hospice Care–Open Journal, 8(2), pp.30-34. http://dx.doi.org/10.17140/PMHCOJ-8-150
Al-Shamsi, H.O., 2022. The state of cancer care in the United Arab Emirates in 2022. Clinics and practice, 12(6), pp.955-985. https://doi.org/10.3390/clinpract12060101
Al-Shamsi, H.O., 2022. Barriers and facilitators to conducting oncology clinical trials in the UAE. Clinics and Practice, 12(6), pp.885-896. https://doi.org/10.3390/clinpract12060093
AlZaabi, A., AlHarrasi, A., AlMusalami, A., AlMahyijari, N., Al Hinai, K., ALAdawi, H. and Al-Shamsi, H.O., 2022. Early onset colorectal cancer: challenges across the cancer care continuum. Annals of Medicine and Surgery, 82. https://pubmed.ncbi.nlm.nih.gov/36268309/
Ennab, F., Tsagkaris, C., Babar, M.S., Tazyeen, S., Kokash, D., Nawaz, F.A. and Al-Shamsi, H.O., 2022. A potential rise of breast cancer risk in the UAE post-COVID-19 lockdown: A call for action. Annals of Medicine and Surgery, 79, p.103976. https://doi.org/10.1016/j.amsu.2022.103976
Aoude, M., Mousallem, M., Abdo, M., Youssef, B., Kourie, H.R. and Al-Shamsi, H.O., 2022. Gastric cancer in the Arab World: a systematic review. Eastern Mediterranean Health Journal, 28(7), pp.521-531. https://iris.who.int/handle/10665/361808
Abou Ghayda, R., Lee, K.H., Han, Y.J., Ryu, S., Hong, S.H., Yoon, S., Jeong, G.H., Yang, J.W., Lee, H.J., Lee, J., Lee, J.Y., Effenberger, M., Eisenhut, M., Kronbichler, A., Solmi, M., Li, H., Jacob, L., Koyanagi, A., Radua, J., Park, M.B., Aghayeva, S., Ahmed, MLCB., Al Serouri, A., Al-Shamsi H.O., Amir-Behghadami, M., et al. 2022. The global case fatality rate of coronavirus disease 2019 by continents and national income: A meta‐analysis. Journal of medical virology, 94(6), pp.2402-2413. https://pmc.ncbi.nlm.nih.gov/articles/PMC9015248/
Al Ashour, B.H., Azam, F., Ibnshamsah, F., Alrowais, F., Al-Garni, A., Al-Shamsi, H.O., Bukhari, N., Ibnshamsa, F., Algarni, A.A. and Al-shamsi, H., 2022. Metastatic type II papillary renal cell carcinoma with recurrent complete responses to sunitinib: a case report with a literature review. Cureus, 14(5). https://pmc.ncbi.nlm.nih.gov/articles/PMC9246320/
Mula-Hussain, L., Mahdi, H., Ramzi, Z.S., Tolba, M., Zaghloul, M.S., Benbrahim, Z., Abusanad, A., Al-Shamsi, H., Bounedjar, A. and Jazieh, A.R., 2022. Cancer burden among Arab world males in 2020: The need for a better approach to improve outcome. JCO Global Oncology, 8, p.e2100407. https://doi.org/10.1200/GO.21.00407
Allehebi, A., Al Kattan, K., Al Rujaib, M., Al Dayel, F., Black, E., Mahrous, M., AlNassar, M., Al Hussaini, H., Al Twairgi, A., Abdelhafeiz, N., Al Omair, A., Shehri, SA., Al-Shamsi, H.O., Jazieh, A.R. 2022. Management of early-stage resected non-small cell lung cancer: Consensus statement of the lung cancer consortium. Cancer Treatment and Research Communications, 31, p.100538. https://doi.org/10.1016/j.ctarc.2022.100538
Al-Shamsi, H.O., Abyad, A.M. and Rafii, S., 2022. A proposal for a National Cancer Control Plan for the UAE: 2022–2026. Clinics and Practice, 12(1), pp.118-132. https://doi.org/10.3390/clinpract12010016
Rafii, S., Tashkandi, E., Bukhari, N. and Al-Shamsi, H.O., 2022. Current status of CRISPR/Cas9 application in clinical cancer research: opportunities and challenges. Cancers, 14(4), p.947. https://doi.org/10.3390/cancers14040947
Al-Shamsi, H.O., Abyad, A., Kaloyannidis, P., El-Saddik, A., Alrustamani, A., Abu Gheida, I., Ziade, A., Dreier, N.W., Ul-Haq, U., Joshua, T.L.A., El Kinge, A.R., et al. 2022. Establishment of the first comprehensive adult and pediatric hematopoietic stem cell transplant unit in the United Arab Emirates: rising to the challenge. Clinics and Practice, 12(1), pp.84-90. https://doi.org/10.3390/clinpract12010010
Ramia, P., Bodgi, L., Mahmoud, D., Mohammad, M.A., Youssef, B., Kopek, N., Al-Shamsi, H., Dagher, M. and Abu-Gheida, I., 2022. Radiation-induced fibrosis in patients with head and neck cancer: a review of pathogenesis and clinical outcomes. Clinical Medicine Insights: Oncology, 16, p.11795549211036898. https://doi.org/10.1177/11795549211036898
Elsamany, S., Elbaiomy, M., Zeeneldin, A., Tashkandi, E., Hassanin, F., Abdelhafeez, N., Al-Shamsi, H., Bukhari, N. and Elemam, O., 2021. Suggested modifications to the management of patients with breast cancer during the COVID-19 pandemic: web-based survey study. JMIR cancer, 7(4), p.e27073. https://doi.org/10.2196/27073
Hodroj, M.H., El Hasbani, G., Al-Shamsi, H.O., Samaha, H., Musallam, K.M. and Taher, A.T., 2022. Clinical burden of hemophilia in older adults: Beyond bleeding risk. Blood Reviews, 53, p.100912. https://doi.org/10.1016/j.blre.2021.100912
Al-Shamsi, H.O., Jaffar, H., Mahboub, B., Khan, F., Albastaki, U., Hammad, S. and Zaabi, A.A., 2021. Early diagnosis of lung cancer in the United Arab Emirates: challenges and strategic recommendations. Clinics and Practice, 11(3), pp.671-678. https://doi.org/10.3390/clinpract11030082
Al-Shamsi, H.O., Abu-Gheida, I., Abdulsamad, A.S., AlAwadhi, A., Alrawi, S., Musallam, K.M., Arun, B. and Ibrahim, N.K., 2021. Molecular spectra and frequency patterns of somatic mutations in Arab women with breast cancer. The oncologist, 26(11), pp.e2086-e2089. https://doi.org/10.1002/onco.13916
Al-Shamsi, H.O., Eric, A. 2021. Successful Vaccination of Patients with History of Severe Anaphylactic Reaction with Pfizer-Biotech COVID-19 Vaccine. Journal of Oncology Research Review & Reports. SRC/JONRR-125. occur up to, 20. https://www.researchgate.net/publication/364024481_Successful_Vaccination_of_Patients_with_History_of_Severe_Anaphylactic_Reaction_with_Pfizer-Biotech_COVID-19_Vaccine
Al-Shamsi, H. O., Alzaabi, A. A., Afrit, M., Abu-Gheida, I., & Musallam, K. M. (2021). Clinicopathological features of gastric cancer in a cohort of Gulf Council countries’ patients: a cross-sectional study of 96 cases. Journal of Oncology Research Review Reports. SRC/JONRR-133, 3. https://www.researchgate.net/publication/351980181_Clinicopathological_Features_of_Gastric_Cancer_in_a_Cohort_of_Gulf_Council_Countries'_Patients_A_Cross-Sectional_Study_of_96_Cases
Al-Shamsi, H., Azribi, F., Abu-Gheida, I., Jaafar, H. and Razek, A.A., 2021. The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Prior to Anti-Cancer Therapy. Journal of Oncology Research Review & Reports. SRC/JONRR-137, 3.
Al-Shamsi, H.O., Iqbal, F., Al Saad, M.S., Dhemre, P.A., Hachem, F.G., et al. 2021. The burden of gynecologic cancers in the UAE. Journal of Oncology Research Reviews & Reports. SRC/JONRR-147. DOI: doi. org/10.47363/JONRR/2021 (2), 143, pp.2-6. https://cancercarespecialtiesmena.com/wp-content/uploads/2023/02/the-burden-of-gynecologic-cancers-in-the-uae.pdf
Bukhari, N., Alshangiti, A., Tashkandi, E., Algarni, M., Al-Shamsi, H.O. and Al-Khallaf, H., 2021. Fluoropyrimidine-induced severe toxicities associated with rare DPYD polymorphisms: case series from Saudi Arabia and a review of the literature. Clinics and Practice, 11(3), pp.467-471. https://doi.org/10.3390/clinpract11030062
Azhar, M., Aziz, F., Almuhairi, S., Alfelasi, M., Elhouni, A., Syed, R., Al-Shamsi, H.O. and Aldahmani, K.M., 2021. Decline in radioiodine use but not total thyroidectomy in thyroid cancer patients treated in the United Arab Emirates-A retrospective study. Annals of Medicine and Surgery, 64, p.102203. https://doi.org/10.1016/j.amsu.2021.102203
Al-Shamsi, H.O., Coomes Eric A. 2021. Higher and Increasing Incidence of Cancer between the Age of 20-49 Years in the UAE Population; A focus Analysis of the UAE National Cancer Registry Data 2015-2017. Journal of Oncology Research Review & Reports. SRC/JONRR-127, 3.
Al-Shamsi, H.O., Sadir Alrawi S., Abdulsamad Ahmed S., Ibrahim, N.k. 2021. A Strong Beliefs and Soft Evidence Underlying Mammography Surveillance Recommendations in Breast Cancer Survivors: A Study in Reflexive Science and Decision-Making. Journal of Oncology Research Review & Reports. SRC/JONRR-131, 3.
Bernstein, E., Shapira, S., Lev-Ari, S., Leshno, A., Sommer, U.A., Galazan, L., Al-Shamsi, H.O., Wolf, I., Shaked, M., Hay Levy, M., Sror, M., et al. 2021. One-stop-shop for cancer screening: A model for the future. DOI: 10.1200/JCO.2021.39.15_suppl.10554. https://www.asco.org/abstracts-presentations/196770
Latif, M.F., Azam, F., Tirmazy, S.H., Bashir, S., Ibnshamsah, F., Al Selwi, W.M., Bukhari, N., Alwbari, A., Alshangiti, A., Gabsi, A. and Al-Shamsi, H.O., 2021. Impact of COVID 19 pandemic on psychological wellbeing of oncology clinicians in MENA (Middle East and North Africa) region. https://doi.org/10.1200/JCO.2021.39.15_suppl.e24105
Al-Shamsi, H., Darr, H., Abu-Gheida, I., Ansari, J., McManus, M.C., Jaafar, H., Tirmazy, S.H., Elkhoury, M., Azribi, F., Jelovac, D., Doufan, T.A., et al. 2020. The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. The Gulf journal of oncology, 1(32), pp.71-87. https://pubmed.ncbi.nlm.nih.gov/32342923/
Al-Shamsi, H.O., Coomes, E.A. and Alrawi, S., 2020. Screening for COVID-19 in asymptomatic patients with cancer in a hospital in the United Arab Emirates. JAMA oncology, 6(10), pp.1627-1628. https://jamanetwork.com/journals/jamaoncology/fullarticle/2766703
Al-Shamsi, H.O., Coomes, E.A., Aldhaheri, K. and Alrawi, S., 2021. Serial screening for COVID-19 in asymptomatic patients receiving anticancer therapy in the United Arab Emirates. JAMA oncology, 7(1), pp.129-131. https://jamanetwork.com/journals/jamaoncology/fullarticle/2772789
Al-Shamsi, H.O., 2020. Rethinking Cancer Screening and Diagnosis During the Covid-19 Pandemic. Journal of Oncology Research Review & Reports. SRC/JORRR/110.
Al-Shamsi, H. O., et al. 2020. Early Onset Colorectal Cancer in the United Arab Emirates, Where do we Stand?”. Acta Scientific Cancer Biology, 4, pp.24-27. https://www.researchgate.net/publication/373894419_Early_Onset_Colorectal_Cancer_in_the_United_Arab_Emirates_Where_do_we_Stand_Mini_Review
Abdel-Wahab, R., Hassan, M.M., George, B., Carmagnani Pestana, R., Xiao, L., Lacin, S., Yalcin, S., Shalaby, A.S., Al-Shamsi, H.O., Raghav, K. and Wolff, R.A., 2020. Impact of integrating insulin-like growth factor 1 levels into model for end-stage liver disease score for survival prediction in hepatocellular carcinoma patients. Oncology, 98(12), pp.836-846. https://doi.org/10.1159/000502482
Al-Shamsi, H.O., Abu-Gheida, I., Rana, S.K., Nijhawan, N., Abdulsamad, A.S., Alrawi, S., Abuhaleeqa, M., Almansoori, T.M., Alkasab, T., Aleassa, E.M. and McManus, M.C., 2020. Challenges for cancer patients returning home during SARS-COV-19 pandemic after medical tourism-a consensus report by the emirates oncology task force. BMC cancer, 20(1), p.641. https://doi.org/10.1186/s12885-020-07115-6
Al‐Shamsi, H.O., Alhazzani, W., Alhuraiji, A., Coomes, E.A., Chemaly, R.F., Almuhanna, M., Wolff, R.A., Ibrahim, N.K., Chua, M.L., Hotte, S.J. and Meyers, B.M., 2020. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID‐19) pandemic: an international collaborative group. The oncologist, 25(6), pp.e936-e945. https://doi.org/10.1634/theoncologist.2020-0213
Iskanderian, R.R., Karmstaji, A., Mohamed, B.K., Alahmed, S., Masri, M.H., Choufani, E., Ahmed, N., Al-Shamsi, H.O. and Grobmyer, S.R., 2020. Outcomes and impact of a universal COVID-19 screening protocol for asymptomatic oncology patients. Gulf J. Oncolog, 1, pp.7-12. https://pubmed.ncbi.nlm.nih.gov/33431356/
Coomes, E.A., Al‐Shamsi, H.O., Meyers, B.M., Alhazzani, W., Alhuraiji, A., Chemaly, R.F., Almuhanna, M., Wolff, R.A., Ibrahim, N.K., Chua, M.L. and Hotte, S.J., 2020. Evolution of Cancer Care in Response to the COVID‐19 Pandemic. The Oncologist, 25(9), pp.e1426-e1427. https://doi.org/10.1634/theoncologist.2020-0451
Al-Shamsi HO et al , Authors Reply: Oncological surgery during COVID-19 pandemic: The need for deep and lasting measures. https://doi.org/10.1634/theoncologist.2020-0451
Jain, A., Borad, M.J., Kelley, R.K., Wang, Y., Abdel-Wahab, R., Meric-Bernstam, F., Baggerly, K.A., Kaseb, A.O., Al-Shamsi, H.O., Ahn, D.H. and DeLeon, T., 2018. Cholangiocarcinoma with FGFR genetic aberrations: a unique clinical phenotype. JCO Precision Oncology, 2, pp.1-12. https://doi.org/10.1200/PO.17.00080
Abdou, E., Pedapenki, R.M., Abouagour, M., Zar, A.R., Dawoud, E., Elshourbagy, D., Al-Shamsi, H.O. and Grande, E., 2020. Patient selection and risk factors in the changing treatment landscape of metastatic renal cell carcinoma. Expert Review of Anticancer Therapy, 20(10), pp.831-840. https://pubmed.ncbi.nlm.nih.gov/32930617/
Coomes, E.A., Al-Shamsi, H.O., Meyers, B.M., Alhazzani, W., Alhuraiji, A., Chemaly, R.F., Almuhanna, M., Wolff, R.A., Ibrahim, N.K., Chua, M.L. and Hotte, S.J., 2020. Authors Reply: How to manage febrile neutropenia during the COVID pandemic? In response to," A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic". The oncologist. https://doi.org/10.1634/theoncologist.2020-0329
Tashkandi, E., Zeeneldin, A., AlAbdulwahab, A., Elemam, O., Elsamany, S., Jastaniah, W., Abdullah, S., Alfayez, M., Jazieh, A.R. and Al-Shamsi, H.O., 2020. Virtual management of patients with cancer during the COVID-19 pandemic: web-based questionnaire study. Journal of medical Internet research, 22(6), p.e19691. https://doi.org/10.2196/19691
Al-Shamsi, H.O. 2020. Mammography screening for breast cancer—the UK Age trial. The Lancet Oncology, 21(11), e505. https://doi.org/10.1016/S1470-2045(20)30492-7
Al-Shamsi, H.O. 2020. COVID-19 Vaccination for Cancer Patients, What Oncologists and Cancer Patients Need to Know?. Journal of Oncology. Research Review & Reports. SRC/JONRR-114.
Suhaili, A.R., Mayank Kothari, M., Sadir Alrawi, S., Al-Shamsi, H.O., 2020. Anterior Mediastinal Mass: A Rare Presentation of Thyroid Mass Compressing Mediastinal Structures. Journal of Oncology. Research Review & Reports. SRC/JORRR-113. https://scispace.com/pdf/anterior-mediastinal-mass-a-rare-presentation-of-thyroid-1otij4ifxb.pdf
Abusanad, A.M. and Al-Shamsi, H.O., 2021. Tele-Oncology: An Emerging Technology in Developing Countries during the COVID-19 Pandemic. New Emirates Medical Journal, 2(1), pp.13-15. http://dx.doi.org/10.2174/0250688201999201109160857
Benbrahim, Z., Al Asiri, M., Al Bahrani, B., AlNassar, M.A.M.A., Al-Shamsi, H.O., Bounedjar, A., El Saghir, N., Fahed, Z., Khatib, S., Khorshid, O.M.R., Labidi, S., et al. 2020. 1737P National approaches to managing cancer care: Responses of countries in the MENA region to COVID-19 pandemic. Annals of Oncology, 31, p.S1016. https://doi.org/10.1016/j.annonc.2020.08.1801
Abdulsamad, A.S., Inam, A., Oner, M., Al-Shamsi, H.O., Alrawi, S.J., et al. 2019. Malignant Peritoneal Mesothelioma Following Wilmsâ€™ Tumor in a Horse-Shoe Kidney, A Case Report and Review of Literature. Cancer Therapy & Oncology International Journal, 13(2), pp.66-71. http://dx.doi.org/10.19080/CTOIJ.2019.13.555859
Al-Shamsi, H.O. and Tareen, M., 2018. Palliative care in the United Arab Emirates, a desperate need. Palliat Med Care, 5(3), pp.1-4. http://dx.doi.org/10.15226/2374-8362/5/3/00161
Al-Shamsi, H.O., Al-Hajeili, M. and Alrawi, S., 2018. Chasing the cure around the globe: medical tourism for cancer care from developing countries. Journal of global oncology, 4, pp.JGO-17. https://pmc.ncbi.nlm.nih.gov/articles/PMC6180774/
Al-Shamsi, H.O., 2018. Expatriates with cancer diagnosis in the United Arab Emirates, hanging on the edge. J Cancer Prev Curr Res, 9(5), pp.257-258. https://eos-uae.com/wp-content/uploads/2020/04/3.-JCPCR-09-00364-1.pdf
Al-Shamsi, H.O. and Alrawi, S., 2018. Breast cancer screening in the United Arab Emirates: is it time to call for a screening at an earlier age. J Cancer Prev Curr Res, 9(3), pp.123-126. https://doi.org/10.15406/jcpcr.2018.09.00334
Al-Shamsi, H.O., Tashkandi, E., Bukhari, N., Al Farsi, A., Alnajjar, A., Alhuraiji, A., Foheidi, M., Sagheir, A., Thani, K.B., Al Bahrani, B. and Alrawi, S., 2018. Awareness, understanding, attitude and barriers toward prescribing modern cancer immunotherapies in the Arabian Gulf countries. Gulf J Oncolog, 1, pp.45-51. https://eos.ae/wp-content/uploads/2020/04/5.-EOS-Awareness-article-2-1.pdf
Bukhari, N., Al-Shamsi, H.O. and Azam, F., 2018. Update on the treatment of metastatic urothelial carcinoma. The Scientific World Journal, 2018(1), p.5682078. https://doi.org/10.1155/2018/5682078
Khan, M. and Al-Shamsi, H.O., 2018. Long-Standing Course of Disease in a Patient with Muir-Torre Syndrome. JOJ Case Stud. 7(3): 555712. https://juniperpublishers.com/jojcs/JOJCS.MS.ID.555712.php
Jones, J.C., Renfro, L.A., Al-Shamsi, H.O., Schrock, A.B., Rankin, A., Zhang, B.Y., et al. 2017. Non-V600 BRAF mutations define a clinically distinct molecular subtype of metastatic colorectal cancer. Journal of Clinical Oncology, 35(23), pp.2624-2630. https://doi.org/10.1200/JCO.2016.71.4394
Meyers, B.M., Al-Shamsi, H.O., Rask, S., Yelamanchili, R., Phillips, C.M., Papaioannou, A., Pond, G.R., Jeyabalan, N., Zbuk, K.M. and Dhesy-Thind, S.K., 2017. Utility of the Edmonton Frail Scale in identifying frail elderly patients during treatment of colorectal cancer. Journal of gastrointestinal oncology, 8(1), p.32. https://doi.org/10.21037/jgo.2016.11.12
Al-Shamsi, H.O., Lau, A.N., Malik, K., Alamri, A., Ioannidis, G., Corbett, T., Adachi, J.D. and Papaioannou, A., 2017. Corrigendum to “The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer”. Journal of Oncology, 2017, pp.1-1. https://doi.org/10.1155/2017/3432604
Abdel-Wahab, R., Hassan, M., Wolff, R.A., Lacin, S., Al-Shamsi, H.O., Raghav, K.P.S., Shalaby, A.S., Yao, J.C. and Kaseb, A.O., 2017. Association of elevated alpha-1 antitrypsin with advanced clinicopathologic features of hepatocellular carcinoma. J Clin Oncol 35, 289-289. https://doi.org/10.1200/JCO.2017.35.4_suppl.289
Al-Shamsi, H.O., Jones, J., Fahmawi, Y., Dahbour, I., Tabash, A., Abdel-Wahab, R., Abousamra, A.O., Shaw, K.R., Xiao, L., Hassan, M.M., Kipp, B.R., et al. 2016. Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern. Journal of gastrointestinal oncology, 7(6), p.882. doi: 10.21037/jgo.2016.11.02 https://jgo.amegroups.org/article/view/10606/9407
Al-Shamsi, H.O. and Ibrahim, N.K., 2016. The addition of bevacizumab to neoadjuvant chemotherapy in HER2-negative inflammatory breast cancer, more not necessarily better. Translational Cancer Research, 5(Suppl 4). doi: 10.21037/tcr.2016.10.82. https://tcr.amegroups.org/article/view/10131/html
Al-Shamsi, H.O., Fahmawi, Y., Dahbour, I., Tabash, A., Rogers, J.E., Mares, J.E., Blum, M.A., Estrella, J., Matamoros Jr, A., Sagebiel, T., Devine, C.E., et al. 2016. Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experience. Journal of Gastrointestinal Oncology, 7(4), p.499. https://doi.org/10.21037/jgo.2016.06.16
Al-Shamsi, H.O., Anand, D., Shroff, R.T., Jain, A., Zuo, M., Conrad, C., Vauthey, J.N. and Javle, M.M., 2016. BRCA-associated protein 1 mutant cholangiocarcinoma: an aggressive disease subtype. Journal of gastrointestinal oncology, 7(4), p.556. https://doi.org/10.21037/jgo.2016.03.05
Al-Shamsi, H.O., Alzahrani, M. and Wolff, R.A., 2016. The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer—a report of two cases. Journal of Gastrointestinal Oncology, 7(3), p.E45. https://doi.org/10.21037/jgo.2016.01.05
Al-Shamsi, H.O., Rogers, J., Mares, J.E., Blum, M.A., Dahbour, I., Fahmawi, Y., Lin, Q. and Ajani, J.A., 2016. Continuation of trastuzumab beyond disease progression in patients with metastatic gastric cancer: A retrospective analysis of 25 cases—The MD Anderson experience. J Clin Oncol 34, e15560(2016). https://doi.org/10.1200/JCO.2016.34.15_suppl.e15560
Kaseb, A.O., Morris, J.S., Iwasaki, M., Al-Shamsi, H.O., Raghav, K.P.S., Girard, L., Cheung, S., Nguyen, V., Elsayes, K.M., Xiao, L., Abdel-Wahab, R., et al. 2016. Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma. OncoTargets and therapy, pp.773-780. https://doi.org/10.2147/ott.s91977
Al-Shamsi, H.O., Abdel-Wahab, R., Hassan, M., Botrus, G., Shalaby, A.S., Wolff, R.A. and Kaseb, A.O., 2016. Natural history of T1N0M0 hepatocellular carcinoma: Large scale study in the United States. J Clin Oncol 34, 416-416(2016). https://doi.org/10.1200/jco.2016.34.4_suppl.416
Al-Shamsi, H.O., Shalaby, A., Dar, A.Y., Hassan, M., Wolff, R.A. and Li, D., 2016. Prognostic effect of angiotensin-converting-enzyme inhibitors (ACEI) and diuretics in patients with pancreatic cancer. J Clin Oncol 34, 420(2016). https://doi.org/10.1200/jco.2016.34.4_suppl.420
Kaseb A, Morris J, Iwasaki M, Al-Shamsi H, Raghav K, Girard L, Cheung S, Nguyen V, Elsayes K, Xiao L, Abdel-Wahab R, Shalaby A, Hassan M, Hassabo H, Wolff R, Yao J. Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma. Onco Targets Ther. 2016;9:773-780. https://doi.org/10.2147/OTT.S91977
Kaseb, A.O., Al-Shamsi, H.O., Morris, J., Iwasaki, M., Xiao, L., Abdel-Wahab, R., Raghav, K.P.S., Hassan, M., Hassabo, H.M. and Wolff, R.A., 2015. P-114 A phase II trial of bevacizumab and erlotinib as second line therapy for advanced hepatocellular carcinoma. Annals of Oncology, 26iv32. https://doi.org/10.1093/annonc/mdv233.114
Al-Shamsi, H.O., Alhazzani, W. and Wolff, R.A., 2015. Extended RAS testing in metastatic colorectal cancer—Refining the predictive molecular biomarkers. Journal of gastrointestinal oncology, 6(3), p.314. https://doi.org/10.3978/j.issn.2078-6891.2015.016
Al-Shamsi, H.O., Kee, B.K., Tetzlaff, M.T. and Wolff, R.A., 2015. Capecitabine-induced leukocytoclastic vasculitis under neoadjuvant chemotherapy for locally advanced colorectal cancer. Journal of Gastrointestinal Oncology, 6(3), p.E40. https://doi.org/10.3978/j.issn.2078-6891.2015.003
Al-Shamsi, H.O., Al Farsi, A., Anjum, M., Shen, H., Zbuk, K., Cook, R.J., Linkins, L.A. and Major, P., 2015. Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil and irinotican (FOLFIRI) plus bevacizumab. Journal of gastrointestinal oncology, 6(3), p.274. https://doi.org/10.3978/j.issn.2078-6891.2015.025
Alhazzani, W., Al-Shamsi, H.O., Greenwald, E., Radhi, J. and Tse, F., 2015. Chronic abdominal pain secondary to mesenteric panniculitis treated successfully with endoscopic ultrasonography-guided celiac plexus block: a case report. World Journal of Gastrointestinal Endoscopy, 7(5), p.563. https://doi.org/10.4253/wjge.v7.i5.563
Javle, M., Churi, C., Kang, H.C., Shroff, R., Janku, F., Surapaneni, R., Zuo, M., Barrera, C., Al-Shamsi, H.O., Krishnan, S., Mishra, L., et al. 2015. HER2/neu-directed therapy for biliary tract cancer. Journal of hematology & oncology, 8(1), p.58. https://doi.org/10.1186/s13045-015-0155-z
Clayton, R., Wu, J., Heng, D.Y., North, S.A., Emmenegger, U., Hotte, S., Chi, K., Zielinski, R., Al-Shamsi, H., Chen, L. and Eigl, B., 2014. A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration-resistant prostate cancer. Canadian Urological Association Journal, 8(9-10), p.E583. https://doi.org/10.5489/cuaj.1891
Al-Shamsi, H.O., Al Farsi, A. and Ellis, P.M., 2014. Stage III Non–Small-Cell Lung Cancer: Establishing a Benchmark for the Proportion of Patients Suitable for Radical Treatment. Clinical Lung Cancer, 15(4), pp.274-280. https://doi.org/10.1016/j.cllc.2014.02.003
Al-Shamsi, H.O., Lau, A.N., Malik, K., Alamri, A., Ioannidis, G., Corbett, T., Adachi, J.D. and Papaioannou, A., 2012. The current practice of screening, prevention, and treatment of androgen‐deprivation‐therapy induced osteoporosis in patients with prostate cancer. Journal of oncology, 2012(1), p.958596. https://doi.org/10.1155/2012/958596
Abstract Number e1513. Al-Shamsi, H.O., Barrera, C.D., Surapaneni, R., Kang, H., Shroff, R.T., Janku, F., Krishnan, S., Zuo, M., Wolff, R.A., Kaseb, A.O. and Thomas, M.B., 2015. HER2/neu-directed therapy for biliary tract cancer. https://doi.org/10.1200/jco.2015.33.15_suppl.e15137
Kaseb, A.O., Al-Shamsi, H.O., Morris, J., Iwasaki, M., Xiao, L., Abdel-Wahab, R., Raghav, K.P.S., Hassan, M., Hassabo, H.M. and Wolff, R.A., 2015. A phase II trial of bevacizumab and erlotinib as second line therapy for advanced hepatocellular carcinoma. J Clin Oncol 33, 4088-4088(2015). https://doi.org/10.1200/jco.2015.33.15_suppl.4088
Meyers, B.M., Al-Shamsi, H.O., and Figueredo, A.T., 2015. Cochrane systematic review and meta-analysis of adjuvant therapy for stage II colon cancer. J Clin Oncol 33, 3513-3513. https://doi.org/10.1200/jco.2015.33.15_suppl.3513
Al-Shamsi, H.O., Abdel-Wahab, R., Hassan, M., Botrus, G., Shalaby, A.S., Wolff, R.A. et al. 2015. Natural History of T1N0M0 Hepatocellular carcinoma: Large scale study in the United States. Oncology, 93(4), 233-242. https://doi.org/10.1200/jco.2015.33.15_suppl.e15120
Dhesy-Thind, S.K., Meyers, B.M., Al-Shamsi, H.O., Papaioannou, A., Zbuk, K.M. and Pond, G.R., 2013. Rapid assessment of frailty prior to treatment of elderly colorectal cancer patients. J Clin Oncol 31, e20522-e20522. https://doi.org/10.1200/jco.2013.31.15_suppl.e20522
Al-Shamsi, H.O., Anjum, M., Al Farsi, A.M., Shen, H., Cook, R.J., Linkins, L.A. and Major, P., 2013. Thrombotic events in metastatic colorectal cancer patients treated with FOLFIRI plus bevacizumab. J Clin Oncol 31, e14630-e14630. https://doi.org/10.1200/jco.2013.31.15_suppl.e14630
Clayton, R., Heng, D.Y.C., Wu, J.S., Zielinski, R., North, S.A., Emmenegger, U., Hotte, S.J., Al-Shamsi, H.O., Chen, L. and Eigl, B.J., 2013. A multicenter population-based experience with abiraterone acetate (AA) in patients with metastatic castration resistant prostate cancer (mCRPC). J Clin Oncol 31, 113-113. https://doi.org/10.1200/jco.2013.31.6_suppl.113
Gastrointestinal Cancers Symposium - American Society of Clinical Oncology – ASCO 2013 meeting : J Clin Oncol 30: 2012 (suppl 34; abstr 540), Venous thromboembolism events in patients with Colorectal Cancer treated with FOLFIRI Plus bevacizumab - JCC Regional cancer centre Experience, Humaid Al-Shamsi MD, FRCPC, Major, P MD
Al-Shamsi, H.O. and Ellis, P.M., 2012. Stage III NSCLC: How many patients are really suitable for radical treatment approaches?. J Clin Oncol 30, e17532-e17532. Supervisor Dr.P.Ellis. https://doi.org/10.1200/jco.2012.30.15_suppl.e17532
Meyers, B.M., Yelamanchili, R., Rask, S., Al-Shamsi, H.O., Phillips, C.M., Papaioannou, A., Zbuk, K.M., Gu, C.S., Jeyabalan, N. and Dhesy-Thind, S.K., 2012. Utility of the Edmonton Frail Scale (EFS) in identifying frail elderly patients during treatment of colorectal cancer (CRC). J Clin Oncol 30, e14001-e14001. https://doi.org/10.1200/jco.2012.30.15_suppl.e14001
Clayton, R., Heng, D.Y.C., Wu, J.S., Zielinski, R., North, S.A., Emmenegger, U., Hotte, S.J., Al-Shamsi, H.O., Chen, L. and Eigl, B.J., 2013. A multicenter population-based experience with abiraterone acetate (AA) in patients with metastatic castration resistant prostate cancer (mCRPC). J Clin Oncol 31, 113-113. https://doi.org/10.1200/jco.2013.31.6_suppl.113
Urban Emmenegger MD4, Sebastian Hotte MD, FRCPC5, Rob Zielinski MD2, Humaid Al-Shamsi MD5, Leo Chen2, Bernhard Eigl MD, FRCPC2. General Poster Session A: colon Cancer Abstract ID: 2382
Clayton, R., Wu, J., Heng, D.Y., North, S.A., Emmenegger, U., Al-Shamsi, H.O., Hotte, S.J. and Eigl, B.J., 2012. Utilization of Radiation Therapy in Metastatic Castration Resistant Prostate Cancer Following the Introduction of Abiraterone into Clinical Oncology Practice. International Journal of Radiation Oncology, Biology, Physics, 84(3), pp.S361-S362. https://doi.org/10.1016/j.ijrobp.2012.07.954
Urban Emmenegger MD4, Sebastian Hotte MD, FRCPC5, Rob Zielinski MD2, Humaid Al-Shamsi MD5, Leo Chen2, Bernhard Eigl MD, FRCPC2.  General Poster Session A: Prostate Cancer, Abstract ID: 113
Stage III NSCLC: How many patients are really suitable for radical treatment approaches? Humaid Al-Shamsi, Dr.P.Ellis
Utility of the Edmonton Frail Scale (EFS) in identifying frail elderly patients during treatment of colorectal cancer (CRC). Brandon M Meyers, Radhika Yelamanchili, Sara Rask, Humaid Al-Shamsi, Callista Maria Phillips, Alexandra Papaioannou, Kevin M. Zbuk, Chu Shu Gu, Neera Jeyabalan, Sukhbinder K. Dhesy-Thind. Clinical Journal of Oncology 2012.
The Current practice of screening, prevention and treatment of Androgen Deprivation Therapy (ADT) induced Osteoporosis in patients with Prostate Cancer. Alshamsi,Humaid, A.Papaioannou
Ontario Thoracic Cancer Conference 2012: Stage III NSCLC: How many patients are really suitable for radical treatment approaches? Supervisor Dr.P.Ellis
Canadian society of internal medicine- Vancouve, BC Oct 2010: The Current practice of screening, prevention and treatment of Androgen Deprivation Therapy (ADT) induced Osteoporosis in patients with Prostate Cancer. Alshamsi,Humaid, A.Papaioannou
Training Tomorrow’s Oncologists at Home: Establishing the UAE’s First Hematology-Oncology Fellowship Training Program (April 2026). https://connection.asco.org/do/training-tomorrow-s-oncologists-home-establishing-uae-s-first-hematology-oncology
Establishing and Launching a Comprehensive Bone Marrow Transplant Unit in the UAE Amidst the COVID-19 Pandemic: Overcoming Barriers Through International Collaboration and Resilience. Humaid O. Al Shamsi (December 2021). https://connection.asco.org/do/establishing-and-launching-comprehensive-bone-marrow-transplant-unit-uae-amidst-covid
ASCO Post: Cancer in the Arab World: Addressing Challenges to Improve Outcomes. Humaid O. Al Shamsi (March 2022). https://ascopost.com/issues/march-10-2022/cancer-in-the-arab-world-addressing-challenges-to-improve-outcomes/
In Press: Book – Palliative Care in the Arab World (CC BY 4.0), by Springer https://www.harvard.com/book/9789819606351 This open-access book explores the growing role of palliative care in the Middle East, reflecting a global shift toward recognizing it as essential to public health and a fundamental right for patients with life-threatening illnesses. The World Health Organization (WHO) defines palliative care as a holistic approach addressing physical, emotional, and spiritual needs, extending beyond treatment to relieve suffering and improve quality of life. Delivered in hospitals, clinics, and homes, it engages families and communities through a multidisciplinary framework.
In Press: Book – Cancer Care in Africa (CC BY 4.0), by Springer
In Press: Book – Cancer in the Arab World (2nd Edition), by Springer

Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC) Jul 2011 – Present License No: 999297
Fellow of the American College of Physicians (FACP) Nov 2013 – Present Membership No: 01379227
Fellow of the Royal College of Physicians (FRCP), London, UK Oct 2023 RCP No: 171754
Fellow of the Royal College of Physicians of Ireland (FRCPI) 9 Apr 2026 RCP No: 19243685
Fellow of the Royal College of Physicians and Surgeons of Glasgow (FRCPG) 21 Feb 2024 RCPSG No: 179812
Fellow of the Royal College of Physicians of Edinburgh (FRCPE) Feb 2025 RCPE No: 884699
Combined Postdoctoral Advanced Clinical Fellowship in Gastrointestinal Oncology and Palliative Oncology Jul 2012 – Sep 2013 McMaster University, Canada
Medical Oncology Fellowship Training Program Jul 2010 – Jun 2012 McMaster University, Canada
Internal Medicine Residency Training Program Jul 2007 – Jun 2010 McMaster University, Canada
Bachelor of Medicine, Bachelor of Surgery (MB BCh BAO) with Honours University College Cork, Ireland Completed Jun 2004 BMedSc (Hons), completed Jun 2002 (awarded 2004)
Royal College of Physicians and Surgeons of Canada Medical Oncology (FRCPC) Nov 2012
American Board of Internal Medicine (ABIM) Medical Oncology Dec 2012
Membership of the Royal College of Physicians (MRCP, UK) – Medical Oncology Oct 2012
Royal College of Physicians and Surgeons of Canada Internal Medicine (FRCPC) Jun 2011
American Board of Internal Medicine (ABIM) Internal Medicine Aug 2010 Scored in the top 10%
National Board of Physicians and Surgeons (USA) Board Certified in Internal Medicine and Medical Oncology 11 Aug 2025
Sheikh Khalifa Distinguished Physician Scholarship Program 2012 – 2014 First graduate of this highly specialized UAE national program aimed at training distinguished physicians at world-class healthcare institutions.
UAE Government Scholarship – Oncology Fellowship Training McMaster University, Hamilton, Canada Jul 2010 – Sep 2013
UAE Government Scholarship – Internal Medicine Residency McMaster University, Hamilton, Canada Jul 2007 – Jun 2010
UAE Government Scholarship – Medical Education University College Cork, Ireland
Dubai Health Authority (DHA), UAE License No: DHA-O-0184997 Consultant in Internal Medicine and Medical Oncology – Active
Department of Health – Abu Dhabi (DOH), UAE License No: GD11570 Medical Oncology Consultant – Issued 03 Jan 2011; Active
Ministry of Health (MOH), UAE License No: D44393 Medical Oncology Consultant – Active
Texas Medical Board, USA Full License No: P7737 Aug 2013 – Expired
College of Physicians and Surgeons of Ontario (CPSO), Canada Full License No: 86148 – Active
Licentiate of the Medical Council of Canada (LMCC) Date: 15 Dec 2010 LMCC No: 112756
Educational Commission for Foreign Medical Graduates (ECFMG), USA Date: 25 Jul 2013
United States Medical Licensing Examination (USMLE) Steps 1, 2, and 3 Completed Aug 2013
Irish Medical Council Fully Registered (2005 – 2006) – Inactive

Chief Executive Officer Burjeel Cancer Institute – Burjeel Medical City – Burjeel Holdings – Abu Dhabi Jul 2024 – Present
Director of Oncology Services – GCC Burjeel Cancer Institute – Burjeel Holdings – Abu Dhabi Jan 2023 – Jul 2024 Led the establishment of the Burjeel oncology network across the GCC, successfully launching operations in Oman and expanding into Saudi Arabia.
Director of Oncology Services & Consultant Medical Oncologist Burjeel Cancer Institute – Burjeel Holdings – Abu Dhabi Oct 2020 – Jan 2023 Established one of the most comprehensive cancer networks in the UAE, spanning seven locations across Abu Dhabi, Dubai, Al Ain, and Sharjah. Oversaw a multidisciplinary team of 17 medical oncologists, radiation oncologists, and hematologists. Established a comprehensive bone marrow transplant unit for both adult and pediatric patients.
Professor (Visiting) Harvard Medical School (HMS), Harvard University Boston, USA Jan 2025 – Present
Visiting Scientist Dana-Farber Cancer Institute, Harvard University Boston, USA Jan 2025 – Present
Professor (Full) Ras Al Khaimah Medical and Health Sciences University Ras Al Khaimah, UAE Jun 2024 – Present
Professor (Adjunct) College of Medicine, University of Sharjah Sharjah, UAE Mar 2021 – Present (renewed May 2023)
Professor (Honorary) College of Medicine, Gulf Medical University Ajman, UAE Jun 2025 – Present
Consultant Medical Oncologist & Head of Medical Oncology Department Al Zahra Hospital, Dubai, UAE Jul 2017 – Dec 2021
Associate Professor (Adjunct) College of Medicine, University of Sharjah Sharjah, UAE Mar 2017 – Apr 2021
Assistant Professor (Full-Time) & Consultant Medical Oncologist Department of Gastrointestinal Medical Oncology MD Anderson Cancer Center, University of Texas Houston, USA Jun 2014 – Dec 2016
Assistant Professor (Adjunct) Department of Medical Oncology Juravinski Cancer Centre, McMaster University Hamilton, Canada Oct 2013 – Jun 2016
Dubai Health Authority – Advanced National Oncology Care Standards (2024) Contributed to the development and national rollout of advanced regulatory standards for oncology services across Dubai, in collaboration with the Dubai Health Authority (DHA), Prof. Humaid O. Al-Shamsi, and the Emirates Oncology Society, strengthening quality, standardization, and cancer care delivery. https://www.wam.ae/en/article/b3udh1m-dubai-health-authority-announces-advanced
Ministry of Health and Prevention (MOHAP) – National Guideline for Lung Cancer Screening and Diagnosis (2025) Played a key role through the Emirates Oncology Society in developing national guidelines for lung cancer screening and diagnosis, establishing a unified, evidence-based framework for early detection and risk stratification across the UAE. https://mohap.gov.ae/en/w/mohap-in-collaboration-with-health-authorities-and-astrazeneca-launches-national-guideline-for-lung-cancer-screening-and-diagnosis
National Multidisciplinary Committee for Cancer Case Assessment (2025) Contributed to the establishment of the National Multidisciplinary Committee for Cancer Case Assessment under Ministerial Decree No. (20) of 2025, formalizing multidisciplinary decision-making and strengthening coordinated cancer care at the national level. https://mohap.gov.ae/en/w/ministerial-decree-no.-20-of-the-year-2025-regarding-the-the-criteria-for-establishing-the-national-multidisciplinary-committee-for-cancer-case-assessment-available-in-arabic-
Clinical Supervisor – Internal Medicine Residents Tawam Hospital, Al Ain, UAE Jul 2017 – Present
Clinical Supervisor – Fellows and Residents MD Anderson Cancer Center, Houston, USA Jun 2014 – Jan 2017
Planner and Organizer – Medical Oncology Journal Club McMaster University Jul 2012 – Jun 2013
OSCE Examiner – Undergraduate MD Program McMaster University Nov 2007 & Jun 2008 Participated as an examiner in OSCE examinations to enhance evaluation and feedback skills.
ECG Crash Course Instructor Dec 2008 & Apr 2009 Prepared and delivered a 6-hour workshop for junior residents and medical students, covering key aspects of ECG interpretation with excellent learner feedback.
Providing ongoing support to junior UAE physicians: Dr. Aydah Alawadi, Mentorship throughout internal medicine training and support to gain fellowship training at MD Anderson Cancer Center, Houston, Texas, USA. Due to complete Medical Oncology fellowship training in June 2019 and planning to do Breast Fellowship at MD Anderson Cancer and Dr. Zaki Ajlan, Mentorship throughout medical school training, one to one advice and support regarding how to choose subspecialty for postgraduate training. Dr. Ajlan was matched to Stanford University internal medicine program, Stanford, California, USA in March 2018 with guaranteed medical oncology fellowship upon the completion of the internal medicine residency program.
Combined Chemo-immunotherapy in NSCLC is it ready for the prime time? Clinical Case Discussion, Immuno-Oncology Summit, Dubai, UAE, December 15, 2019
SP147 assay PDL-1 interpretation in clinical practice (NSCLC and GU cancers) - PDL-1 workshop for pathologist from the gulf region (KSA, Iraq, UAE), Dubai, December 16, 2019
Colorectal and breast cancer guidelines workshop – The gulf federation for cancer control, Member of the gulf federation for cancer control taskforce for colorectal and breast cancer guidelines, Kuwait City, Kuwait, Nov 26-27, 2018
The role of bevacizumab in advanced colorectal cancer, Journal club, Dubai, UAE, Nov 20, 2019
Defining the Genomic Landscape of Colorectal Cancer, Emirates Oncology Conference, Abu Dhabi, Nov 17, 2019
Update in the management of advanced colorectal cancer in the second line setting, Oman Cancer conference, Muscat, Oman, Oct 12, 2018
Defining the Genomic Landscape of Colorectal Cancer, UAE Cancer congress, Dubai, UAE, Oct 6, 2017
Advances in the management of metastatic castrate resistant prostate cancer, UAE Cancer congress, Dubai, UAE, Oct 6, 2019
Sharjah Morning program interview, World Cancer Day, explained to the public in simple language the importance of early cancer screening. https://www.youtube.com/watch?v=xE3KEyJpygs
Friends of cancer event – Early cancer screening – a talk targeted to the general public audience titled “Early cancer detection, When and How?” 20-Jan-2018.
Free medical consultation for Cancer patient at Al Zahra Hospital – Dubai Jul 2017 - Present

President, Emirates Oncology Society (EOS) Nov 2018 – Present https://eos-uae.com/
Chairman, UAE Oncology and Hematology Fellowship Training Program National Institute for Health Specialties May 2022 – Present
Member, UAE National Committee Present
Society Chair, Gulf Cancer Society Present https://gulfcancersociety.com/
Chairman, Colon Cancer Guidelines Committee (MENA) – NCCN Dec 2021 – Present
President, Gulf Oncology Society Dec 2021 – Jul 2025
Member, Lung Cancer Policy Network Present https://www.lungcancerpolicynetwork.com/members/humaid-al-shamsi/
Member, Steering Committee – National Cancer Control Indicators Ministry of Health, UAE Jan 2018 – Present
Member, Department of Health Oncology Task Force Jan 2019 – Present
Editorial Board Member, Journal of Global Oncology Aug 2017 – Present
Member, Emirates Oncology Society 2017 – Present
Member, International Society of Gastrointestinal Oncology (ISGIO) Jan 2014 – Present
Member, American Society of Clinical Oncology (ASCO) Nov 2013 – Present
Member, European Society for Medical Oncology (ESMO) Nov 2013 – Present
Fellow, Royal College of Physicians and Surgeons of Canada (FRCPC) Jul 2011 – Present
Fellow, American College of Physicians (FACP) 2007 – Present
Member, Canadian Medical Protective Association 2007 – Present
Member, UAE Medical Association 2006 – Present

The Dr. Pat Kennedy Award Apr 2026 The inaugural Dr. Pat Kennedy Award was presented in April 2026 in recognition of Prof. Humaid Al-Shamsi’s outstanding contributions to advancing cancer care.
Sheikha Fatima bint Mubarak Program for Excellence and Community Intelligence Award (7th Cycle) Feb 2025 Category: Honorary Family Category Awarded by His Highness Sheikh Mohamed bin Zayed Al Nahyan, President of the UAE, in recognition of outstanding contributions to community leadership and social impact, particularly in the role as President of the Emirates Oncology Society and CEO of Burjeel Cancer Institute. https://www.wam.ae/en/article/bieay6y-uae-president-confers-%E2%80%98order-the-mother-the
UAE President Receives Professor Humaid Al Shamsi 2025 https://www.nmo.gov.ae/en/news/uae-president-receives-professor-humaid-al-shamsi
NAFIS Award May 2024 Awarded first place by HH Sheikh Mansour bin Zayed Al Nahyan, Vice President of the UAE, for outstanding leadership in the private sector across business and medical disciplines. https://gulfnews.com/business/corporate-news/burjeel-holdings-excels-at-nafis-award-secures-three-first-places-for-emirati-talent-development-1.1715695805906
Feigenbaum Leadership Excellence Award – Accomplished Leaders Category Sheikh Hamdan Bin Mohammed Smart University Mar 2022 Awarded in recognition of exemplary leadership and contributions to organizational excellence and quality-driven culture in the Arab world.
Sharjah Award for Voluntary Work May 2022 Recognized for cancer awareness efforts in the UAE and the region.
UAE Genetic Diseases Association (UAEGDA) Distinguished Clinical Award May 2022 Awarded for contributions to advancing cancer care in the UAE, including the establishment of a bone marrow transplantation unit. https://twitter.com/NET_AD/status/1530124525769203712
First Graduate – Sheikh Khalifa bin Zayed Distinguished Physician Training Program 2016 https://www.albayan.ae/across-the-uae/news-and-reports/2018-02-12-1.3184386
The Oncologist Journal Jul 2020 Awarded by Editor-in-Chief Bruce A. Chabner (Massachusetts General Hospital, Harvard Medical School) for the publication: “A Practical Approach to the Management of Cancer Patients During the COVID-19 Pandemic: An International Collaborative Group.” https://theoncologist.onlinelibrary.wiley.com/journal/1549490x/homepage/anniversaryretrospective
Outstanding Researcher of the Year Emirates Medical Association Sep 2020 Recognized for publishing over 10 research papers in high-impact journals.
Researcher of the Year Emirates Medical Association Sep 2021 Recognized for publishing over 20 research papers. https://eos-uae.com/2nd-eos-annual-conference/
EOS Cancer Awareness Advocate of the Year 2021 https://eos-uae.com/2nd-eos-annual-conference/
Certificate of Appreciation UAE Embassy, Washington, D.C., USA 2012 Awarded for excellence in clinical and research performance during fellowship training at McMaster University.
MSA (Medical Staff Association) Outstanding Senior Resident of the Year Award McMaster University, Canada 2012 Nominated by the Medical Oncology Department; one of three awards across Hamilton Health Sciences among approximately 150 trainees.
Jeff Ginsberg Subspecialty Resident Award McMaster University, Canada 2012 Nominated by the Medical Oncology Program Director; one award across all Internal Medicine subspecialties.
Runner-Up – Chief Resident of the Year Internal Medicine Training Program 2009 – 2010 Recognized for excellence in medical education and administrative leadership during chief residency at Hamilton General Hospital (Jan 2010 – Mar 2010).
Internal Medicine Chief’s Cup 2009 – 2010 Member of the Hamilton General Hospital Internal Medicine Chief’s Team.
Certificate of Appreciation UAE Embassy, London, UK 2004 Awarded for achieving honors in Bachelor of Medicine and Surgery at University College Cork.
Stuart Jay Cohen Memorial Award – 1st Place Student Research Day, Department of Oncology, McMaster University 2012
Clinical Research – Poster Presentation: Venous thromboembolism events in patients with colorectal cancer treated with FOLFIRI plus bevacizumab – Juravinski Cancer Centre experience (Supervisor: Dr. P. Major).
Stuart Jay Cohen Memorial Award – 2nd Place Student Research Day, Department of Oncology, McMaster University 2012
Clinical Research – Oral Presentation: “The current practice of screening, prevention, and treatment of androgen deprivation therapy-induced osteoporosis in patients with prostate cancer” (Supervisor: Dr. Alexandra Papaioannou).

Al-Shamsi, Humaid O. "Healthcare in the United Arab Emirates" https://link.springer.com/book/10.1007/978-981-96-0523-1
Al-Shamsi, Humaid O. "Cancer Care in the United Arab Emirates" https://link.springer.com/book/10.1007/978-981-99-6794-0
Al-Shamsi, Humaid O., Ibrahim H. Abu-Gheida, Faryal Iqbal, and Aydah Al-Awadhi. "Cancer in the Arab World." The book has been downloaded more than 500,000 times within the first two years of publication. https://link.springer.com/book/10.1007/978-981-16-7945-2
Al-Shamsi, H.O., & Iqbal, F. (2025). History of healthcare in the UAE. In Healthcare in the United Arab Emirates (pp. 1–32). Singapore: Springer Nature Singapore. https://link.springer.com/chapter/10.1007/978-981-96-0523-1_1
Al-Shamsi, H.O., Al Dhaheri, A., Shersad, F., & Al-Houqani, M. (2025). National Institute for Health Specialties (NIHS) in the UAE. In Healthcare in the United Arab Emirates (pp. 111–122). Singapore: Springer Nature Singapore. https://link.springer.com/chapter/10.1007/978-981-96-0523-1_8
Ganesan, S., Al-Shamsi, H.O., Mostafa, M., & Zaher, W.A. (2025). Research productivity of health sciences institutions in the UAE: A 20-year bibliometric analysis. In Healthcare in the United Arab Emirates (pp. 201–215). Singapore: Springer Nature Singapore. https://link.springer.com/chapter/10.1007/978-981-96-0523-1_15
Al-Shamsi, H.O., & Iqbal, F. (2025). Cancer care in the UAE. In H.O. Al-Shamsi (Ed.), Healthcare in the United Arab Emirates. Singapore: Springer. https://doi.org/10.1007/978-981-96-0523-1_26
Nijhawan, N.A., Al-Shamsi, H.O., & Ibrahim, H. (2025). Palliative and hospice medicine in the UAE. In Healthcare in the United Arab Emirates (pp. 413–429). Singapore: Springer Nature Singapore. https://link.springer.com/chapter/10.1007/978-981-96-0523-1_27
Al-Shamsi, H.O., Thwaini, A., Iqbal, F., Darwish, O., Rao, A., Janahi, F., Rahman, A.A., Al-Qudah, H., & Al Kasab, T. (2025). Urology in the UAE. In Healthcare in the United Arab Emirates (pp. 521–543). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-96-0523-1_34
Mendonca, V., & Al-Shamsi, H.O. (2025). The future of healthcare in the UAE. In Healthcare in the United Arab Emirates (pp. 841–848). Singapore: Springer Nature Singapore. https://link.springer.com/chapter/10.1007/978-981-96-0523-1_52
Al-Shamsi, H.O. (2024). Introduction. In H.O. Al-Shamsi (Ed.), Cancer Care in the United Arab Emirates. Singapore: Springer. https://doi.org/10.1007/978-981-99-6794-0_1
Al-Shamsi, H.O., & Abyad, A.M. (2024). Cancer care in the UAE. In Cancer Care in the United Arab Emirates (pp. 15–56). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_2
Rafii, S., & Al-Shamsi, H.O. (2024). Cancer prevention, screening, and early detection in the UAE. In Cancer Care in the United Arab Emirates (pp. 79–90). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_4
Al-Shamsi, H.O., & Abyad, A.M. (2024). A proposal for a cancer control plan in the UAE. In Cancer Care in the United Arab Emirates (pp. 91–126). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_5
Al-Shamsi, H.O., & Abyad, A.M. (2024). Comprehensive cancer centers in the UAE. In Cancer Care in the United Arab Emirates (pp. 127–135). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_6
Al-Shamsi, H.O., & Abyad, A.M. (2024). Emirates Oncology Society. In Cancer Care in the United Arab Emirates (pp. 137–151). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_7
Al-Shamsi, H.O. (2024). Factors influencing seeking cancer care abroad for UAE citizens. In Cancer Care in the United Arab Emirates (pp. 153–161). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_8
Ganesan, S., Al-Shamsi, H.O., Mostafa, M., & Zaher, W.A. (2024). Clinical cancer research in the UAE. In Cancer Care in the United Arab Emirates (pp. 175–192). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_10
Al-Shamsi, H.O. (2024). Oncology and hematology fellowship training in the UAE. In Cancer Care in the United Arab Emirates (pp. 209–214). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_12
Nijhawan, N.A., & Al-Shamsi, H.O. (2024). Palliative care in the UAE. In Cancer Care in the United Arab Emirates (pp. 359–376). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_22
Al-Awadhi, A., Iqbal, F., Kourie, H.R., & Al-Shamsi, H.O. (2024). Breast cancer in the UAE. In Cancer Care in the United Arab Emirates (pp. 417–434). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_26
Al-Shamsi, H.O., Iqbal, F., Kourie, H.R., Al Zaabi, A.A., Abyad, A.M., & Abdelwahed, N. (2024). Colorectal cancer in the UAE. In Cancer Care in the United Arab Emirates (pp. 435–450). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_27
Abdelwahed, N., Al Asousi, S., Iqbal, F., Abyad, A.M., Nijhawan, N.A., Kourie, H.R., Abu-Gheida, I.H., Ammori, B., & Al-Shamsi, H.O. (2024). Gastric cancer in the UAE. In Cancer Care in the United Arab Emirates (pp. 451–472). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_28
Al-Shamsi, H.O., Iqbal, F., Nijhawan, N.A., Kourie, H.R., Abdelwahed, N., Abu-Gheida, I.H., & Ammori, B. (2024). Pancreatic cancer in the UAE. In Cancer Care in the United Arab Emirates (pp. 473–489). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_29
Bendardaf, R., Talaat, I.M., Elemam, N.M., & Al-Shamsi, H.O. (2024). Thyroid cancer in the UAE. In Cancer Care in the United Arab Emirates (pp. 545–557). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_32
Rafii, S., Aboud, B., & Al-Shamsi, H.O. (2024). Lung cancer in the UAE. In Cancer Care in the United Arab Emirates (pp. 559–568). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_33
Sawan, S., Iqbal, F., & Al-Shamsi, H.O. (2024). Gynecologic malignancies in the UAE. In Cancer Care in the United Arab Emirates (pp. 569–580). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_34
Shahait, M., Al-Qudah, H., Mula-Hussain, L., Abu-Gheida, I.H., Alkasab, T., Thwaini, A., Madi, R., Al-Shamsi, H.O., Tirmazy, S.H., & Mukherji, D. (2024). Genitourinary malignancies in the UAE. In Cancer Care in the United Arab Emirates (pp. 581–592). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_35
Al-Awadhi, A., & Al-Shamsi, H.O. (2024). Neuroendocrine tumors (NETs) in the UAE. In Cancer Care in the United Arab Emirates (pp. 597–601). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_37
Al-Shamsi, H.O., Abyad, A.M., Kanakande Kandy, Z.A., George, B., Dar-Yahya, M., Kaloyannidis, P., El-Saddik, A., Rana, S., & Khalil, C. (2024). Hematopoietic stem cell transplantation (HSCT) in the UAE. In Cancer Care in the United Arab Emirates (pp. 611–624). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_39
Al-Shamsi, H.O. (2024). Suggested quality control measures for cancer care in the UAE. In Cancer Care in the United Arab Emirates (pp. 629–637). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-6794-0_41
Abu-Gheida, I.H., Nijhawan, N.A., Al-Awadhi, A., & Al-Shamsi, H.O. (2022). General oncology care in the UAE. In Cancer in the Arab World (pp. 301–319). Singapore: Springer. https://doi.org/10.1007/978-981-16-7945-2_19
Al-Shamsi, H.O., & Iqbal, F. (2022). General oncology care in Qatar, Comoros, and Djibouti. In Cancer in the Arab World (pp. 339–352). Singapore: Springer. https://doi.org/10.1007/978-981-16-7945-2_21
Al-Shamsi, H.O., Iqbal, F., & Abu-Gheida, I.H. (2022). Introduction. In Cancer in the Arab World. Singapore: Springer. https://doi.org/10.1007/978-981-16-7945-2_1
Nijhawan, N.A., & Al-Shamsi, H.O. (2021). Palliative care in the United Arab Emirates. In Handbook of Healthcare in the Arab World (pp. 2315–2332). Cham: Springer International Publishing. https://doi.org/10.1007/978-3-319-74365-3_102-1
Abu-Gheida, I.H., Nijhawan, N.A., & Al-Shamsi, H.O. (2021). Oncology care in the UAE. In Handbook of Healthcare in the Arab World (pp. 521–538). Cham: Springer International Publishing. https://doi.org/10.1007/978-3-319-74365-3_183-1
Al-Shamsi, H., Hansel, D.E., Bellmunt, J., & Siefker-Radtke, A.O. (2017). Uncommon cancers of the bladder. In Textbook of Uncommon Cancer. https://doi.org/10.1002/9781119196235.ch5
Al-Shamsi, H., Siefker-Radtke, A.O., Czerniak, B., Dinney, C., & Millikan, R.E. (2016). Uncommon cancers of the bladder. In Textbook of Uncommon Cancer (5th ed.). John Wiley & Sons.
Jarrah, M.M., Al‐Shamsi, H.O., Abuhelwa, Z., Bustanji, Y., Semreen, M.H., McKinnon, R.A., Sorich, M.J., Hopkins, A.M. and Abuhelwa, A.Y., 2026. Treatment‐Specific Prediction Models in Multiple Myeloma: A Critical Review of Current Evidence and Future Directions. European Journal of Haematology. https://onlinelibrary.wiley.com/doi/full/10.1111/ejh.70177
Abuhelwa, A.Y., Almansour, S.A., Al-Shamsi, H.O., Abuhelwa, Z., Alqudah, M.A., Bustanji, Y., Semreen, M.H., Alzoubi, K.H., Modi, N.D., McKinnon, R.A. and Sorich, M.J., 2026. Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trials. Scientific Reports. https://doi.org/10.1038/s41598-026-37464-4
Moshi, J.M., Abdelwahab, S.I., Taha, M.M.E., Alamer, D.A., Maashi, H.M., Badri, R.M., Jeraiby, M., Maashi, S.M., Majrashi, E.J.M., Bajawi, Y.A. and Al‐Shamsi, H.O., 2026. Breast Cancer Awareness and Screening Predictors in Young Saudi Women: Findings From a Cross‐Sectional Study. Health Science Reports, 9(3), p.e71831. https://doi.org/10.1002/hsr2.71831
Abuhelwa, A.Y., Almansour, S.A., Al-Shamsi, H.O., Abuhelwa, Z., Ziade, M.A., McKinnon, R.A., Sorich, M.J. and Hopkins, A.M., 2026. HSR26-204: Baseline EORTC QLQ-C30 “Clinically Important” Symptom Burden Predicts Survival and Toxicity in CLL/SLL Across Randomized Ibrutinib Trials. Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7459
Abdelwahab, S.I., Taha, M.M.E., Farasani, A., Abdullah, S.M., Alshahrani, S., Assiri, A., Moshi, J.M., Khamjan, N.A., Al-Shamsi, H., Alshahrani, A.F. and Mohan, S., 2026. Emerging Trends and Conceptual Mapping in Network Pharmacology Research: A Bibliometric Analysis (2008-2023) Using VOSviewer. Ind. J. Pharm. Edu. Res, 60(2s), pp.s651-s662. DOI: 10.5530/ijper.20262593. https://nchr.elsevierpure.com/en/publications/emerging-trends-and-conceptual-mapping-in-network-pharmacology-re/
Al-Shamsi, H.O., Rasul Snr, K., Shablak, A., ALnajjar, A., Shabaan, A.M.A., Al Sindi, M., Nasr, M., AlJabban, A. and Rafii, S., 2025. Diagnosis and Management of Colorectal Cancer in the Gulf Area: Current Practice and Future Suggestions from Expert Opinions. OncoTargets and Therapy, pp.1265-1279. https://doi.org/10.2147/ott.s535858
Latif, M.F., Tirmazy, S.H., Hamza, D.M., Das, K., Omara, M., Basit, A., Saber, N. and Al-Shamsi, H.O., 2025. 59eP Correlation between Oncotype Dx recurrence score and clinicopathological factors in early breast cancer: A retrospective single institution study, Dubai Hospital, Dubai, UAE. Annals of Oncology, 36, p.S1784. https://doi.org/10.1016/j.annonc.2025.10.893
Rafii, S., Mukherji, D., Komaranchath, A.S., Khalil, C., Iqbal, F., Abdelwahab, S.I., Abyad, A., Abuhelwa, A.Y., Gandikota, L. and Al-Shamsi, H.O., 2025. Advancing CAR T-cell therapy in solid tumors: current landscape and future directions. Cancers, 17(17), p.2898. https://doi.org/10.3390/cancers17172898
Syrigos, K.N., Bussell, M.E., Al-Shamsi, H.O., Khorshid, O., Herbst, R.S., Agelaki, S., Leighl, N., Hirsch, F. and Wakelee, H., 2025. Bridging the gap in lung cancer: A comprehensive global strategy for change. European Journal of Cancer, p.116069. https://doi.org/10.1016/j.ejca.2025.116069
Moshi, J.M., Abdelwahab, S.I., Taha, M.M.E., Albasheer, O., Abdullah, S.M., Farasani, A., Jeraiby, M.A., Al-Shamsi, H.O., Hakami, A.M.S., Khamjan, N.A. and Alshahrani, S., 2025. Cancer research in Saudi Arabia: A cross-sectional mapping study of historical growth, thematic analysis, collaboration patterns, and future directions. Medicine, 104(39), p.e44757. DOI: 10.1097/MD.0000000000044757. https://journals.lww.com/md-journal/fulltext/2025/09260/cancer_research_in_saudi_arabia__a_cross_sectional.36.aspx
Mukherji, D., Agarwal, M., Al-Shamsi, H.O., Angel, M., Da Rosa, D.A.R., Limaye, S., Talreja, V., El Morsi, W., Ürün, Y. and Grande, E., 2026. Social media for healthcare professionals in oncology: results from a cross-sectional survey conducted across eight countries in Asia, Latin America, and the Middle East. Future Oncology, 22(2), pp.203-216. https://doi.org/10.1080/14796694.2025.2548192
Kandy, Z.A.K., Nivargi, S., Chaudhary, B., Ramzan, M., Abdullah, F., Aboobacker, F., Khalil, C., Porta, F., Faulkner, L. and Alshamsi, H., 2025. Outcomes of hematopoietic stem cell transplantation (HSCT) from matched related donors in pediatric patients: insights from a single center in the United Arab Emirates. Cureus, 17(8). DOI: 10.7759/cureus.89239. https://www.cureus.com/articles/372874#!/
Jagadeesan, S., Kalyanasundaram, K., Alghamdi, M., Mohammed, M., Sweidan, R., Abdalqader, A., Sonawane, Y., Al-Shamsi, H. and Abu-Gheida, I., 2025. Feasibility of a robust and homogeneous volumetric modulated arc therapy based total body irradiation technique and analysis of dose rate using Elekta solutions. Medical Dosimetry. https://doi.org/10.1016/j.meddos.2025.06.003
Shehab, A., Al Dhanhani, H., Alhammadi, O., Hassan, M.B., Farghaly, M., Hassoun, A., Mahboub, B., Tahlak, M., Abutayeh, R.F., Haridy, H., Hassanien, A., Joury J., Al-Shamsi, H. O. 2025. Strategies for the Prevention and Management of Respiratory Infections in Patients at High Risk in the UAE: A Cross-Disciplinary Position Paper. Pulmonary Therapy, 11(3), pp.405-421. https://doi.org/10.1007/s41030-025-00304-3
Abdelwahab, S.I., Moni, S.S., Taha, M.M.E., Sahli, K.A., Alqhtani, H.A.S., Farasani, M.M., Qadri, M., Alarifi, A., Khardali, A., Alsaadi, K.H., Farasani, A., Khamjan A. Nizar., Al-Shamsi, H. O. et al. 2025. Mapping breast cancer research on monoclonal antibodies: a data-driven approach using VOSviewer, Bibliometrix, and CiteSpace. Naunyn-Schmiedeberg's Archives of Pharmacology, pp.1-21. https://doi.org/10.1007/s00210-025-04401-7
Mukherji, D., Fadhil, I., Faraj, W., Rafii, S. and Al-Shamsi, H.O., 2025. Cancer control in the United Arab Emirates. The Lancet Oncology. https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00077-4/abstract
Shreenivas AV, Cristofanilli M, Limaye SA, Gaya AM, Crook T, Ajami R, Mokbel K, Schaffrin-Nabe D, Al-Shamsi H.O., Mandal TK, Shingla S. Molecular profiling of body fluid cfDNA: Advancing diagnostics and therapeutic decisions. https://doi.org/10.1200/JCO.2025.43.16_suppl.3054
Patil, D., Grewal, U.S., Vaid, A.K., Advani, S.H., Shingla, S., Varshney, A.N., Gaya, A.M., Al-Shamsi, H.O., Wilson, J., Mandal, T.K. and Crook, T., 2025. Molecular diversity in neuroendocrine tumors: A house divided. https://ascopubs.org/doi/pdf/10.1200/JCO.2025.43.16_suppl.e15170
Abuhelwa, A.Y., Almansour, S.A., Basch, E., Al‐Shamsi, H.O., Abuhelwa, Z., Bustanji, Y., Semreen, M.H., Kharaba, Z., Ali, S.M., Mohamed, R. and Kichenadasse, G., 2025. Predictive and Prognostic Significance of Patient‐Reported Outcomes for Survival and Adverse Events in Daratumumab‐Treated Multiple Myeloma. European Journal of Haematology, 114(6), pp.1020-1031. https://doi.org/10.1111/ejh.14410
Abdelwahab, S.I., Taha, M.M.E., Sahli, K.A., Alqhtani, H.A.S., Farasani, A., Khamjan, N.A., Al-Shamsi, H., Moshi, J.M., Alshahrani, S., Assiri, A. and Qadri, M., 2025. Graphene-based biosensors for PSA. Clinica Chimica Acta, 576, p.120406. https://doi.org/10.1016/j.cca.2025.120406
Abuhelwa, A.Y., Almansour, S.A., Brown, J.R., Al-Shamsi, H.O., Abuhelwa, Z., Kharaba, Z., Bustanji, Y., Semreen, M.H., Ali, S., Alhuraiji, A. and McKinnon, R.A., 2025. Statin use and survival in CLL/SLL treated with ibrutinib: pooled analysis of 4 randomized controlled trials. Blood advances, 9(14), pp.3566-3575. https://doi.org/10.1182/bloodadvances.2024015287
El-Deiry W.S., Bresson C., Wunder F., Carneiro B.A., Dizon D.S., Warner J.L., Graff S.L., Azzoli C.G., Wong E.T., Cheng L., Mani S.A., Safran H.P., Williams C., Meissner T., Solomon B., Rubin E., Porgador A., Berchem G., Saintigny P., Onn A., Bar J., Berger R., Gantenbein M., Chen Z., Souza C.P., Reis R.M.V., Sekacheva M., Cervantes A., Dahut W.L., Annunziata C.M., Gober K., Musallam KM., Al-Shamsi H.O., Abu-Gheida I., Salazar R., et. Al. 2025. Worldwide innovative network (WIN) consortium in personalized cancer medicine: bringing next-generation precision oncology to patients. Oncotarget, 16, p.140. https://doi.org/10.18632/oncotarget.28703
Al-Shamsi, H.O., Abdelwahed, N. and Mokbel, K., 2025. Surveillance Systemic Imaging After Curative Intent for Breast Cancer: A Double Standard?. Journal of Clinical Oncology, 43(1), pp.109-111. https://doi.org/10.1200/JCO.24.01186
Nijhawan, N.A., Al-Shamsi, H., Sweeting, K., Mustafa, R., Sheikh, A., Khan, J.K., Tareen, M., Safi, A.M. and Hami, F., 2025. Palliative care in United Arab Emirates: Response to The Lancet Commission on the value of death. Eastern Mediterranean Health Journal, 31(12), pp.666-668. https://doi.org/10.26719/2025.31.12.666
Al-Shamsi, H.O., Oner, M. and Mokbel, K., 2025. Balancing evidence and individualization in adjuvant CDK4/6 therapy. Translational Cancer Research, 14(8), pp.4479-4481. https://doi.org/10.21037/tcr-2025-879
Al-Shamsi, H.O., Patil, D.S., Limaye, S., Vaid, A.K., Datar, R., Fuller-Shavel, N., Lechner, M., Krupashankar, S., Shah, D.K., Shingla, S. and Datta, A., 2025. 151P Exosomal miRNA-based classification of breast cancer subtypes in patients unsuitable for tissue biopsy. Annals of Oncology, 36, p.S266. https://doi.org/10.1016/j.annonc.2025.08.585
Limaye, S., Datar, R., Syed, N., Ghaisas, A., Akolkar, D., Chougule, R., ... & Al-Shamsi, H. O. 2025. 1747P Real-world performance of an AI-driven U-Net-Based pipeline for automated detection of circulating tumor cells (CTCs) in a screening population. Annals of Oncology, 36, p.S1025. https://doi.org/10.1016/j.annonc.2025.08.2376
Kaloyannidis, P., George, B., Alrustamani, A., Khalil, C., Al-Charfli, B., Al-Moghrabi, N., ... & Al-Shamsi, H.O. 2024. Paving the Road for Haematopoietic Stem Cell Transplantation in the United Arab Emirates: A Single Centre’s Experience. Journal of Blood Medicine, pp.471-475. https://doi.org/10.2147/jbm.s468665
Albaldawy, M.J., Ebaied, T., Al Shamsi, H.O., Nadaf, A., Abbu, R.U.F. and Al Shamsi, H.O., 2024. Adult-Onset Pediatric-Type Follicular Lymphoma of the Parotid Gland. Cureus, 16(12). https://doi.org/10.7759/cureus.76161
Abusanad, A., Alawadi, A., Mukharji, D., Abualkair, O., Almansoori, N., Alsindi, M. and Al-Shamsi, H.O., 2024. Insights and solutions for advancing and empowering women in oncology from the Gulf Cooperation Council Countries. ESMO open, 9(10), p.103723. https://doi.org/10.1016/j.esmoop.2024.103723
Almansour, S.A., Alqudah, M.A., Abuhelwa, Z., Al-Shamsi, H.O., Alhuraiji, A., Semreen, M.H., Bustanji, Y., Alzoubi, K.H., Modi, N.D., Mckinnon, R.A. and Sorich, M.J., 2024. Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials. Therapeutic Advances in Medical Oncology, 16, p.17588359241275387. https://doi.org/10.1177/17588359241275387
Al‐Shamsi, H.O. and Musallam, K.M., 2024. Not only a Western world issue: Cancer incidence in younger individuals in the United Arab Emirates. CA: A Cancer Journal for Clinicians, 74(3). https://doi.org/10.3322/caac.21839
Al-Shamsi, H.O., Abdelwahab, S.I., Albasheer, O., Taha, M.M.E., Alqassim, A.Y., Alharbi, A., Farasani, A., Altraifi, A.A.A., Medani, I.E., Hakami, N. and Abdelmola, A.O., 2024. Cancer research in the United Arab Emirates from birth to present: A bibliometric analysis. Heliyon, 10(6). https://doi.org/10.1016/j.heliyon.2024.e27201
Allehebi, A., Al-Omair, A., Mahboub, B., Koegelenberg, C.F., Mokhtar, M., Madkour, A.M., Al-Asad, K., Selek, U. and Al-Shamsi, H.O., 2024. Recommended approaches for screening and early detection of lung cancer in the Middle East and Africa (MEA) region: a consensus statement. Journal of Thoracic Disease, 16(3), pp.2142-2158. https://pmc.ncbi.nlm.nih.gov/articles/PMC11009596/
Laguna, J.C., Garcia-Pardo, M., Alessi, J., Barrios, C., Singh, N., Al-Shamsi, H.O., Loong, H., Ferriol, M., Recondo, G. and Mezquita, L., 2024. Geographic differences in lung cancer: focus on carcinogens, genetic predisposition, and molecular epidemiology. Therapeutic advances in medical oncology, 16, p.17588359241231260. https://doi.org/10.1177/17588359241231260
Almansour, S.A., Alqudah, M.A., Abuhelwa, Z., Al-Shamsi, H.O., Semreen, M.H., Bustanji, Y., Soare, N.C., McKinnon, R.A., Sorich, M.J., Hopkins, A.M. and Abuhelwa, A.Y., 2024. Association of proton pump inhibitor use with survival and adverse effects outcomes in patients with multiple myeloma: pooled analysis of three clinical trials. Scientific Reports, 14(1), p.591. https://doi.org/10.1038/s41598-023-48640-1
Al-Shamsi, H.O., Abdelwahed, N., Abyad, A., Abu-Gheida, I., Afrit, M., Abu ElFuol, T., Alasas, R., Lababidi, B., Dash, P., Ahmad, M., Dreier, N.W., et al. 2023. Breast cancer in the Arabian Gulf countries. Cancers, 15(22), p.5398. https://doi.org/10.3390/cancers15225398
Abbas, N.F., Aoude, M.R., Kourie, H.R. and Al-Shamsi, H.O., 2024. Uncovering the epidemiology of bladder cancer in the Arab world: A review of risk factors, molecular mechanisms, and clinical features. Asian Journal of Urology, 11(3), pp.406-422. https://doi.org/10.1016/j.ajur.2023.10.001
Al-Shamsi, H.O., Abdelwahed, N., Singh, M., Abyad, A.M., Elsabae, S., Abdelgawad, T., Iqbal, F., Ibrahim, N. 2023. First reported case of successful conception and delivery during stage IV breast cancer treatment: A case report and literature review. Cureus, 15(10). https://doi.org/10.7759/cureus.47201
Al-Shamsi, H.O., Abu-Gheida, I., Sameh, K., Tahoun, N.E. and Musallam, K.M., 2023. Arab countries and oncology clinical trials: A bibliometric analysis. Cancers, 15(18), p.4428. https://doi.org/10.3390/cancers15184428
Elkaddoum, R., Zakhour, J., Hajal, M., Aoun, M., Njeim, M., Mahrous, M., Al-Shamsi, H.O., Brahim, Z.B., Khatib, S.A. and Kourie, H.R., 2023. Improving the management of ALK-rearranged non-small-cell lung cancer through a mobile application: a physicians-based survey. Pharmacogenomics, 24(13), pp.725-730. https://pubmed.ncbi.nlm.nih.gov/37706248/
Kourie, H.R., Mahrous, M., Naim, N., Zouein, J., Benbrahim, Z., Rasul, K., Mokhtar, M., Shehri, A.A., Shakeeb, M., Khatib, S. and Al-Shamsi, H., 2023. The first Middle East and North Africa expert consensus recommendations for management of advanced gastric cancer. https://pubmed.ncbi.nlm.nih.gov/37526151/
Humaid Al-Shamsi, S., Humaid Al-Shamsi, A., Humaid Al-Shamsi, M., Sajwani, A., Alzaabi, M.S., Al Hammadi, O., Iqbal, F. and Al-Shamsi, H.O., 2023. The perception and awareness of the public about cancer and cancer screening in the United Arab Emirates, a population-based survey. Clinics and Practice, 13(3), pp.701-714. https://doi.org/10.3390/clinpract13030064
Bernstein, E., Lev-Ari, S., Shapira, S., Leshno, A., Sommer, U., Al-Shamsi, H., Shaked, M., Segal, O., Galazan, L., Hay-Levy, M., Sror, M., et al. 2023. Data from a one-stop-shop comprehensive cancer screening center. Journal of Clinical Oncology, 41(14), pp.2503-2510. https://doi.org/10.1200/JCO.22.00938
Albarrak, J. and Al-Shamsi, H., 2023. Current status of management of hepatocellular carcinoma in the Gulf region: challenges and recommendations. Cancers, 15(7), p.2001. https://doi.org/10.3390/cancers15072001
Abboud, K., Umoru, G., Esmail, A., Abudayyeh, A., Murakami, N., Al-Shamsi, H.O., Javle, M., Saharia, A., Connor, A.A., Kodali, S., Ghobrial, R.M., and Abdelrahim M. 2023. Immune checkpoint inhibitors for solid tumors in the adjuvant setting: current progress, future directions, and role in transplant oncology. Cancers, 15(5), p.1433. https://doi.org/10.3390/cancers15051433
Park, S.H., Hong, S.H., Kim, K., Lee, S.W., Yon, D.K., Jung, S.J., Abdeen, Z., Ghayda, R.A., Ahmed, M.L.C.B., Serouri, A.A., Al‐Herz, W., Al-Shamsi, H.O., Ali, S., et al. 2023. Nonpharmaceutical interventions reduce the incidence and mortality of COVID‐19: A study based on the survey from the International COVID‐19 Research Network (ICRN). Journal of Medical Virology, 95(2), p.e28354. https://doi.org/10.1002/jmv.28354
Halaseh, S.A., Al-Karadsheh, A., Mukherji, D., Alhjahaja, A., Farkouh, A.A., Al-Ibraheem, A., Gheida, I.A., Al-Khateeb, S., Al-Shamsi, H. and Shahait, M., 2023. Prostate cancer clinical trials in low-and middle-income countries. ecancermedicalscience, 17, p.1629. https://doi.org/10.3332/ecancer.2023.1629
Baqain, L., Mukherji, D., Al-Shamsi, H.O., Abu-Gheida, I., Al Ibraheem, A., Al Rabii, K., Farkouh, A.A. and Shahait, M., 2023. Quality and reliability of YouTube videos in Arabic as a source of patient information on prostate cancer. ecancermedicalscience, 17, p.1573. https://pmc.ncbi.nlm.nih.gov/articles/PMC10393303/
Al-Shamsi, H.O., Abdelwahed, N., Al-Awadhi, A., Albashir, M., Abyad, A.M., Rafii, S., Afrit, M., Al Lababidi, B., Abu-Gheida, I., Sonawane, Y.P., Nijhawan, N.A.,et al. 2023. Breast cancer in the United Arab Emirates. JCO Global Oncology, 9, p.e2200247. https://doi.org/10.1200/GO.22.00247
Nijhawan, N.A. and Al-Shamsi, H.O., 2022. Experiences and challenges of a new palliative care service in the United Arab Emirates. Palliative Medicine and Hospice Care–Open Journal, 8(2), pp.30-34. http://dx.doi.org/10.17140/PMHCOJ-8-150
Al-Shamsi, H.O., 2022. The state of cancer care in the United Arab Emirates in 2022. Clinics and practice, 12(6), pp.955-985. https://doi.org/10.3390/clinpract12060101
Al-Shamsi, H.O., 2022. Barriers and facilitators to conducting oncology clinical trials in the UAE. Clinics and Practice, 12(6), pp.885-896. https://doi.org/10.3390/clinpract12060093
AlZaabi, A., AlHarrasi, A., AlMusalami, A., AlMahyijari, N., Al Hinai, K., ALAdawi, H. and Al-Shamsi, H.O., 2022. Early onset colorectal cancer: challenges across the cancer care continuum. Annals of Medicine and Surgery, 82. https://pubmed.ncbi.nlm.nih.gov/36268309/
Ennab, F., Tsagkaris, C., Babar, M.S., Tazyeen, S., Kokash, D., Nawaz, F.A. and Al-Shamsi, H.O., 2022. A potential rise of breast cancer risk in the UAE post-COVID-19 lockdown: A call for action. Annals of Medicine and Surgery, 79, p.103976. https://doi.org/10.1016/j.amsu.2022.103976
Aoude, M., Mousallem, M., Abdo, M., Youssef, B., Kourie, H.R. and Al-Shamsi, H.O., 2022. Gastric cancer in the Arab World: a systematic review. Eastern Mediterranean Health Journal, 28(7), pp.521-531. https://iris.who.int/handle/10665/361808
Abou Ghayda, R., Lee, K.H., Han, Y.J., Ryu, S., Hong, S.H., Yoon, S., Jeong, G.H., Yang, J.W., Lee, H.J., Lee, J., Lee, J.Y., Effenberger, M., Eisenhut, M., Kronbichler, A., Solmi, M., Li, H., Jacob, L., Koyanagi, A., Radua, J., Park, M.B., Aghayeva, S., Ahmed, MLCB., Al Serouri, A., Al-Shamsi H.O., Amir-Behghadami, M., et al. 2022. The global case fatality rate of coronavirus disease 2019 by continents and national income: A meta‐analysis. Journal of medical virology, 94(6), pp.2402-2413. https://pmc.ncbi.nlm.nih.gov/articles/PMC9015248/
Al Ashour, B.H., Azam, F., Ibnshamsah, F., Alrowais, F., Al-Garni, A., Al-Shamsi, H.O., Bukhari, N., Ibnshamsa, F., Algarni, A.A. and Al-shamsi, H., 2022. Metastatic type II papillary renal cell carcinoma with recurrent complete responses to sunitinib: a case report with a literature review. Cureus, 14(5). https://pmc.ncbi.nlm.nih.gov/articles/PMC9246320/
Mula-Hussain, L., Mahdi, H., Ramzi, Z.S., Tolba, M., Zaghloul, M.S., Benbrahim, Z., Abusanad, A., Al-Shamsi, H., Bounedjar, A. and Jazieh, A.R., 2022. Cancer burden among Arab world males in 2020: The need for a better approach to improve outcome. JCO Global Oncology, 8, p.e2100407. https://doi.org/10.1200/GO.21.00407
Allehebi, A., Al Kattan, K., Al Rujaib, M., Al Dayel, F., Black, E., Mahrous, M., AlNassar, M., Al Hussaini, H., Al Twairgi, A., Abdelhafeiz, N., Al Omair, A., Shehri, SA., Al-Shamsi, H.O., Jazieh, A.R. 2022. Management of early-stage resected non-small cell lung cancer: Consensus statement of the lung cancer consortium. Cancer Treatment and Research Communications, 31, p.100538. https://doi.org/10.1016/j.ctarc.2022.100538
Al-Shamsi, H.O., Abyad, A.M. and Rafii, S., 2022. A proposal for a National Cancer Control Plan for the UAE: 2022–2026. Clinics and Practice, 12(1), pp.118-132. https://doi.org/10.3390/clinpract12010016
Rafii, S., Tashkandi, E., Bukhari, N. and Al-Shamsi, H.O., 2022. Current status of CRISPR/Cas9 application in clinical cancer research: opportunities and challenges. Cancers, 14(4), p.947. https://doi.org/10.3390/cancers14040947
Al-Shamsi, H.O., Abyad, A., Kaloyannidis, P., El-Saddik, A., Alrustamani, A., Abu Gheida, I., Ziade, A., Dreier, N.W., Ul-Haq, U., Joshua, T.L.A., El Kinge, A.R., et al. 2022. Establishment of the first comprehensive adult and pediatric hematopoietic stem cell transplant unit in the United Arab Emirates: rising to the challenge. Clinics and Practice, 12(1), pp.84-90. https://doi.org/10.3390/clinpract12010010
Ramia, P., Bodgi, L., Mahmoud, D., Mohammad, M.A., Youssef, B., Kopek, N., Al-Shamsi, H., Dagher, M. and Abu-Gheida, I., 2022. Radiation-induced fibrosis in patients with head and neck cancer: a review of pathogenesis and clinical outcomes. Clinical Medicine Insights: Oncology, 16, p.11795549211036898. https://doi.org/10.1177/11795549211036898
Elsamany, S., Elbaiomy, M., Zeeneldin, A., Tashkandi, E., Hassanin, F., Abdelhafeez, N., Al-Shamsi, H., Bukhari, N. and Elemam, O., 2021. Suggested modifications to the management of patients with breast cancer during the COVID-19 pandemic: web-based survey study. JMIR cancer, 7(4), p.e27073. https://doi.org/10.2196/27073
Hodroj, M.H., El Hasbani, G., Al-Shamsi, H.O., Samaha, H., Musallam, K.M. and Taher, A.T., 2022. Clinical burden of hemophilia in older adults: Beyond bleeding risk. Blood Reviews, 53, p.100912. https://doi.org/10.1016/j.blre.2021.100912
Al-Shamsi, H.O., Jaffar, H., Mahboub, B., Khan, F., Albastaki, U., Hammad, S. and Zaabi, A.A., 2021. Early diagnosis of lung cancer in the United Arab Emirates: challenges and strategic recommendations. Clinics and Practice, 11(3), pp.671-678. https://doi.org/10.3390/clinpract11030082
Al-Shamsi, H.O., Abu-Gheida, I., Abdulsamad, A.S., AlAwadhi, A., Alrawi, S., Musallam, K.M., Arun, B. and Ibrahim, N.K., 2021. Molecular spectra and frequency patterns of somatic mutations in Arab women with breast cancer. The oncologist, 26(11), pp.e2086-e2089. https://doi.org/10.1002/onco.13916
Al-Shamsi, H.O., Eric, A. 2021. Successful Vaccination of Patients with History of Severe Anaphylactic Reaction with Pfizer-Biotech COVID-19 Vaccine. Journal of Oncology Research Review & Reports. SRC/JONRR-125. occur up to, 20. https://www.researchgate.net/publication/364024481_Successful_Vaccination_of_Patients_with_History_of_Severe_Anaphylactic_Reaction_with_Pfizer-Biotech_COVID-19_Vaccine
Al-Shamsi, H. O., Alzaabi, A. A., Afrit, M., Abu-Gheida, I., & Musallam, K. M. (2021). Clinicopathological features of gastric cancer in a cohort of Gulf Council countries’ patients: a cross-sectional study of 96 cases. Journal of Oncology Research Review Reports. SRC/JONRR-133, 3. https://www.researchgate.net/publication/351980181_Clinicopathological_Features_of_Gastric_Cancer_in_a_Cohort_of_Gulf_Council_Countries'_Patients_A_Cross-Sectional_Study_of_96_Cases
Al-Shamsi, H., Azribi, F., Abu-Gheida, I., Jaafar, H. and Razek, A.A., 2021. The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Prior to Anti-Cancer Therapy. Journal of Oncology Research Review & Reports. SRC/JONRR-137, 3.
Al-Shamsi, H.O., Iqbal, F., Al Saad, M.S., Dhemre, P.A., Hachem, F.G., et al. 2021. The burden of gynecologic cancers in the UAE. Journal of Oncology Research Reviews & Reports. SRC/JONRR-147. DOI: doi. org/10.47363/JONRR/2021 (2), 143, pp.2-6. https://cancercarespecialtiesmena.com/wp-content/uploads/2023/02/the-burden-of-gynecologic-cancers-in-the-uae.pdf
Bukhari, N., Alshangiti, A., Tashkandi, E., Algarni, M., Al-Shamsi, H.O. and Al-Khallaf, H., 2021. Fluoropyrimidine-induced severe toxicities associated with rare DPYD polymorphisms: case series from Saudi Arabia and a review of the literature. Clinics and Practice, 11(3), pp.467-471. https://doi.org/10.3390/clinpract11030062
Azhar, M., Aziz, F., Almuhairi, S., Alfelasi, M., Elhouni, A., Syed, R., Al-Shamsi, H.O. and Aldahmani, K.M., 2021. Decline in radioiodine use but not total thyroidectomy in thyroid cancer patients treated in the United Arab Emirates-A retrospective study. Annals of Medicine and Surgery, 64, p.102203. https://doi.org/10.1016/j.amsu.2021.102203
Al-Shamsi, H.O., Coomes Eric A. 2021. Higher and Increasing Incidence of Cancer between the Age of 20-49 Years in the UAE Population; A focus Analysis of the UAE National Cancer Registry Data 2015-2017. Journal of Oncology Research Review & Reports. SRC/JONRR-127, 3.
Al-Shamsi, H.O., Sadir Alrawi S., Abdulsamad Ahmed S., Ibrahim, N.k. 2021. A Strong Beliefs and Soft Evidence Underlying Mammography Surveillance Recommendations in Breast Cancer Survivors: A Study in Reflexive Science and Decision-Making. Journal of Oncology Research Review & Reports. SRC/JONRR-131, 3.
Bernstein, E., Shapira, S., Lev-Ari, S., Leshno, A., Sommer, U.A., Galazan, L., Al-Shamsi, H.O., Wolf, I., Shaked, M., Hay Levy, M., Sror, M., et al. 2021. One-stop-shop for cancer screening: A model for the future. DOI: 10.1200/JCO.2021.39.15_suppl.10554. https://www.asco.org/abstracts-presentations/196770
Latif, M.F., Azam, F., Tirmazy, S.H., Bashir, S., Ibnshamsah, F., Al Selwi, W.M., Bukhari, N., Alwbari, A., Alshangiti, A., Gabsi, A. and Al-Shamsi, H.O., 2021. Impact of COVID 19 pandemic on psychological wellbeing of oncology clinicians in MENA (Middle East and North Africa) region. https://doi.org/10.1200/JCO.2021.39.15_suppl.e24105
Al-Shamsi, H., Darr, H., Abu-Gheida, I., Ansari, J., McManus, M.C., Jaafar, H., Tirmazy, S.H., Elkhoury, M., Azribi, F., Jelovac, D., Doufan, T.A., et al. 2020. The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. The Gulf journal of oncology, 1(32), pp.71-87. https://pubmed.ncbi.nlm.nih.gov/32342923/
Al-Shamsi, H.O., Coomes, E.A. and Alrawi, S., 2020. Screening for COVID-19 in asymptomatic patients with cancer in a hospital in the United Arab Emirates. JAMA oncology, 6(10), pp.1627-1628. https://jamanetwork.com/journals/jamaoncology/fullarticle/2766703
Al-Shamsi, H.O., Coomes, E.A., Aldhaheri, K. and Alrawi, S., 2021. Serial screening for COVID-19 in asymptomatic patients receiving anticancer therapy in the United Arab Emirates. JAMA oncology, 7(1), pp.129-131. https://jamanetwork.com/journals/jamaoncology/fullarticle/2772789
Al-Shamsi, H.O., 2020. Rethinking Cancer Screening and Diagnosis During the Covid-19 Pandemic. Journal of Oncology Research Review & Reports. SRC/JORRR/110.
Al-Shamsi, H. O., et al. 2020. Early Onset Colorectal Cancer in the United Arab Emirates, Where do we Stand?”. Acta Scientific Cancer Biology, 4, pp.24-27. https://www.researchgate.net/publication/373894419_Early_Onset_Colorectal_Cancer_in_the_United_Arab_Emirates_Where_do_we_Stand_Mini_Review
Abdel-Wahab, R., Hassan, M.M., George, B., Carmagnani Pestana, R., Xiao, L., Lacin, S., Yalcin, S., Shalaby, A.S., Al-Shamsi, H.O., Raghav, K. and Wolff, R.A., 2020. Impact of integrating insulin-like growth factor 1 levels into model for end-stage liver disease score for survival prediction in hepatocellular carcinoma patients. Oncology, 98(12), pp.836-846. https://doi.org/10.1159/000502482
Al-Shamsi, H.O., Abu-Gheida, I., Rana, S.K., Nijhawan, N., Abdulsamad, A.S., Alrawi, S., Abuhaleeqa, M., Almansoori, T.M., Alkasab, T., Aleassa, E.M. and McManus, M.C., 2020. Challenges for cancer patients returning home during SARS-COV-19 pandemic after medical tourism-a consensus report by the emirates oncology task force. BMC cancer, 20(1), p.641. https://doi.org/10.1186/s12885-020-07115-6
Al‐Shamsi, H.O., Alhazzani, W., Alhuraiji, A., Coomes, E.A., Chemaly, R.F., Almuhanna, M., Wolff, R.A., Ibrahim, N.K., Chua, M.L., Hotte, S.J. and Meyers, B.M., 2020. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID‐19) pandemic: an international collaborative group. The oncologist, 25(6), pp.e936-e945. https://doi.org/10.1634/theoncologist.2020-0213
Iskanderian, R.R., Karmstaji, A., Mohamed, B.K., Alahmed, S., Masri, M.H., Choufani, E., Ahmed, N., Al-Shamsi, H.O. and Grobmyer, S.R., 2020. Outcomes and impact of a universal COVID-19 screening protocol for asymptomatic oncology patients. Gulf J. Oncolog, 1, pp.7-12. https://pubmed.ncbi.nlm.nih.gov/33431356/
Coomes, E.A., Al‐Shamsi, H.O., Meyers, B.M., Alhazzani, W., Alhuraiji, A., Chemaly, R.F., Almuhanna, M., Wolff, R.A., Ibrahim, N.K., Chua, M.L. and Hotte, S.J., 2020. Evolution of Cancer Care in Response to the COVID‐19 Pandemic. The Oncologist, 25(9), pp.e1426-e1427. https://doi.org/10.1634/theoncologist.2020-0451
Al-Shamsi HO et al , Authors Reply: Oncological surgery during COVID-19 pandemic: The need for deep and lasting measures. https://doi.org/10.1634/theoncologist.2020-0451
Jain, A., Borad, M.J., Kelley, R.K., Wang, Y., Abdel-Wahab, R., Meric-Bernstam, F., Baggerly, K.A., Kaseb, A.O., Al-Shamsi, H.O., Ahn, D.H. and DeLeon, T., 2018. Cholangiocarcinoma with FGFR genetic aberrations: a unique clinical phenotype. JCO Precision Oncology, 2, pp.1-12. https://doi.org/10.1200/PO.17.00080
Abdou, E., Pedapenki, R.M., Abouagour, M., Zar, A.R., Dawoud, E., Elshourbagy, D., Al-Shamsi, H.O. and Grande, E., 2020. Patient selection and risk factors in the changing treatment landscape of metastatic renal cell carcinoma. Expert Review of Anticancer Therapy, 20(10), pp.831-840. https://pubmed.ncbi.nlm.nih.gov/32930617/
Coomes, E.A., Al-Shamsi, H.O., Meyers, B.M., Alhazzani, W., Alhuraiji, A., Chemaly, R.F., Almuhanna, M., Wolff, R.A., Ibrahim, N.K., Chua, M.L. and Hotte, S.J., 2020. Authors Reply: How to manage febrile neutropenia during the COVID pandemic? In response to," A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic". The oncologist. https://doi.org/10.1634/theoncologist.2020-0329
Tashkandi, E., Zeeneldin, A., AlAbdulwahab, A., Elemam, O., Elsamany, S., Jastaniah, W., Abdullah, S., Alfayez, M., Jazieh, A.R. and Al-Shamsi, H.O., 2020. Virtual management of patients with cancer during the COVID-19 pandemic: web-based questionnaire study. Journal of medical Internet research, 22(6), p.e19691. https://doi.org/10.2196/19691
Al-Shamsi, H.O. 2020. Mammography screening for breast cancer—the UK Age trial. The Lancet Oncology, 21(11), e505. https://doi.org/10.1016/S1470-2045(20)30492-7
Al-Shamsi, H.O. 2020. COVID-19 Vaccination for Cancer Patients, What Oncologists and Cancer Patients Need to Know?. Journal of Oncology. Research Review & Reports. SRC/JONRR-114.
Suhaili, A.R., Mayank Kothari, M., Sadir Alrawi, S., Al-Shamsi, H.O., 2020. Anterior Mediastinal Mass: A Rare Presentation of Thyroid Mass Compressing Mediastinal Structures. Journal of Oncology. Research Review & Reports. SRC/JORRR-113. https://scispace.com/pdf/anterior-mediastinal-mass-a-rare-presentation-of-thyroid-1otij4ifxb.pdf
Abusanad, A.M. and Al-Shamsi, H.O., 2021. Tele-Oncology: An Emerging Technology in Developing Countries during the COVID-19 Pandemic. New Emirates Medical Journal, 2(1), pp.13-15. http://dx.doi.org/10.2174/0250688201999201109160857
Benbrahim, Z., Al Asiri, M., Al Bahrani, B., AlNassar, M.A.M.A., Al-Shamsi, H.O., Bounedjar, A., El Saghir, N., Fahed, Z., Khatib, S., Khorshid, O.M.R., Labidi, S., et al. 2020. 1737P National approaches to managing cancer care: Responses of countries in the MENA region to COVID-19 pandemic. Annals of Oncology, 31, p.S1016. https://doi.org/10.1016/j.annonc.2020.08.1801
Abdulsamad, A.S., Inam, A., Oner, M., Al-Shamsi, H.O., Alrawi, S.J., et al. 2019. Malignant Peritoneal Mesothelioma Following Wilmsâ€™ Tumor in a Horse-Shoe Kidney, A Case Report and Review of Literature. Cancer Therapy & Oncology International Journal, 13(2), pp.66-71. http://dx.doi.org/10.19080/CTOIJ.2019.13.555859
Al-Shamsi, H.O. and Tareen, M., 2018. Palliative care in the United Arab Emirates, a desperate need. Palliat Med Care, 5(3), pp.1-4. http://dx.doi.org/10.15226/2374-8362/5/3/00161
Al-Shamsi, H.O., Al-Hajeili, M. and Alrawi, S., 2018. Chasing the cure around the globe: medical tourism for cancer care from developing countries. Journal of global oncology, 4, pp.JGO-17. https://pmc.ncbi.nlm.nih.gov/articles/PMC6180774/
Al-Shamsi, H.O., 2018. Expatriates with cancer diagnosis in the United Arab Emirates, hanging on the edge. J Cancer Prev Curr Res, 9(5), pp.257-258. https://eos-uae.com/wp-content/uploads/2020/04/3.-JCPCR-09-00364-1.pdf
Al-Shamsi, H.O. and Alrawi, S., 2018. Breast cancer screening in the United Arab Emirates: is it time to call for a screening at an earlier age. J Cancer Prev Curr Res, 9(3), pp.123-126. https://doi.org/10.15406/jcpcr.2018.09.00334
Al-Shamsi, H.O., Tashkandi, E., Bukhari, N., Al Farsi, A., Alnajjar, A., Alhuraiji, A., Foheidi, M., Sagheir, A., Thani, K.B., Al Bahrani, B. and Alrawi, S., 2018. Awareness, understanding, attitude and barriers toward prescribing modern cancer immunotherapies in the Arabian Gulf countries. Gulf J Oncolog, 1, pp.45-51. https://eos.ae/wp-content/uploads/2020/04/5.-EOS-Awareness-article-2-1.pdf
Bukhari, N., Al-Shamsi, H.O. and Azam, F., 2018. Update on the treatment of metastatic urothelial carcinoma. The Scientific World Journal, 2018(1), p.5682078. https://doi.org/10.1155/2018/5682078
Khan, M. and Al-Shamsi, H.O., 2018. Long-Standing Course of Disease in a Patient with Muir-Torre Syndrome. JOJ Case Stud. 7(3): 555712. https://juniperpublishers.com/jojcs/JOJCS.MS.ID.555712.php
Jones, J.C., Renfro, L.A., Al-Shamsi, H.O., Schrock, A.B., Rankin, A., Zhang, B.Y., et al. 2017. Non-V600 BRAF mutations define a clinically distinct molecular subtype of metastatic colorectal cancer. Journal of Clinical Oncology, 35(23), pp.2624-2630. https://doi.org/10.1200/JCO.2016.71.4394
Meyers, B.M., Al-Shamsi, H.O., Rask, S., Yelamanchili, R., Phillips, C.M., Papaioannou, A., Pond, G.R., Jeyabalan, N., Zbuk, K.M. and Dhesy-Thind, S.K., 2017. Utility of the Edmonton Frail Scale in identifying frail elderly patients during treatment of colorectal cancer. Journal of gastrointestinal oncology, 8(1), p.32. https://doi.org/10.21037/jgo.2016.11.12
Al-Shamsi, H.O., Lau, A.N., Malik, K., Alamri, A., Ioannidis, G., Corbett, T., Adachi, J.D. and Papaioannou, A., 2017. Corrigendum to “The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer”. Journal of Oncology, 2017, pp.1-1. https://doi.org/10.1155/2017/3432604
Abdel-Wahab, R., Hassan, M., Wolff, R.A., Lacin, S., Al-Shamsi, H.O., Raghav, K.P.S., Shalaby, A.S., Yao, J.C. and Kaseb, A.O., 2017. Association of elevated alpha-1 antitrypsin with advanced clinicopathologic features of hepatocellular carcinoma. J Clin Oncol 35, 289-289. https://doi.org/10.1200/JCO.2017.35.4_suppl.289
Al-Shamsi, H.O., Jones, J., Fahmawi, Y., Dahbour, I., Tabash, A., Abdel-Wahab, R., Abousamra, A.O., Shaw, K.R., Xiao, L., Hassan, M.M., Kipp, B.R., et al. 2016. Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern. Journal of gastrointestinal oncology, 7(6), p.882. doi: 10.21037/jgo.2016.11.02 https://jgo.amegroups.org/article/view/10606/9407
Al-Shamsi, H.O. and Ibrahim, N.K., 2016. The addition of bevacizumab to neoadjuvant chemotherapy in HER2-negative inflammatory breast cancer, more not necessarily better. Translational Cancer Research, 5(Suppl 4). doi: 10.21037/tcr.2016.10.82. https://tcr.amegroups.org/article/view/10131/html
Al-Shamsi, H.O., Fahmawi, Y., Dahbour, I., Tabash, A., Rogers, J.E., Mares, J.E., Blum, M.A., Estrella, J., Matamoros Jr, A., Sagebiel, T., Devine, C.E., et al. 2016. Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experience. Journal of Gastrointestinal Oncology, 7(4), p.499. https://doi.org/10.21037/jgo.2016.06.16
Al-Shamsi, H.O., Anand, D., Shroff, R.T., Jain, A., Zuo, M., Conrad, C., Vauthey, J.N. and Javle, M.M., 2016. BRCA-associated protein 1 mutant cholangiocarcinoma: an aggressive disease subtype. Journal of gastrointestinal oncology, 7(4), p.556. https://doi.org/10.21037/jgo.2016.03.05
Al-Shamsi, H.O., Alzahrani, M. and Wolff, R.A., 2016. The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer—a report of two cases. Journal of Gastrointestinal Oncology, 7(3), p.E45. https://doi.org/10.21037/jgo.2016.01.05
Al-Shamsi, H.O., Rogers, J., Mares, J.E., Blum, M.A., Dahbour, I., Fahmawi, Y., Lin, Q. and Ajani, J.A., 2016. Continuation of trastuzumab beyond disease progression in patients with metastatic gastric cancer: A retrospective analysis of 25 cases—The MD Anderson experience. J Clin Oncol 34, e15560(2016). https://doi.org/10.1200/JCO.2016.34.15_suppl.e15560
Kaseb, A.O., Morris, J.S., Iwasaki, M., Al-Shamsi, H.O., Raghav, K.P.S., Girard, L., Cheung, S., Nguyen, V., Elsayes, K.M., Xiao, L., Abdel-Wahab, R., et al. 2016. Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma. OncoTargets and therapy, pp.773-780. https://doi.org/10.2147/ott.s91977
Al-Shamsi, H.O., Abdel-Wahab, R., Hassan, M., Botrus, G., Shalaby, A.S., Wolff, R.A. and Kaseb, A.O., 2016. Natural history of T1N0M0 hepatocellular carcinoma: Large scale study in the United States. J Clin Oncol 34, 416-416(2016). https://doi.org/10.1200/jco.2016.34.4_suppl.416
Al-Shamsi, H.O., Shalaby, A., Dar, A.Y., Hassan, M., Wolff, R.A. and Li, D., 2016. Prognostic effect of angiotensin-converting-enzyme inhibitors (ACEI) and diuretics in patients with pancreatic cancer. J Clin Oncol 34, 420(2016). https://doi.org/10.1200/jco.2016.34.4_suppl.420
Kaseb A, Morris J, Iwasaki M, Al-Shamsi H, Raghav K, Girard L, Cheung S, Nguyen V, Elsayes K, Xiao L, Abdel-Wahab R, Shalaby A, Hassan M, Hassabo H, Wolff R, Yao J. Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma. Onco Targets Ther. 2016;9:773-780. https://doi.org/10.2147/OTT.S91977
Kaseb, A.O., Al-Shamsi, H.O., Morris, J., Iwasaki, M., Xiao, L., Abdel-Wahab, R., Raghav, K.P.S., Hassan, M., Hassabo, H.M. and Wolff, R.A., 2015. P-114 A phase II trial of bevacizumab and erlotinib as second line therapy for advanced hepatocellular carcinoma. Annals of Oncology, 26iv32. https://doi.org/10.1093/annonc/mdv233.114
Al-Shamsi, H.O., Alhazzani, W. and Wolff, R.A., 2015. Extended RAS testing in metastatic colorectal cancer—Refining the predictive molecular biomarkers. Journal of gastrointestinal oncology, 6(3), p.314. https://doi.org/10.3978/j.issn.2078-6891.2015.016
Al-Shamsi, H.O., Kee, B.K., Tetzlaff, M.T. and Wolff, R.A., 2015. Capecitabine-induced leukocytoclastic vasculitis under neoadjuvant chemotherapy for locally advanced colorectal cancer. Journal of Gastrointestinal Oncology, 6(3), p.E40. https://doi.org/10.3978/j.issn.2078-6891.2015.003
Al-Shamsi, H.O., Al Farsi, A., Anjum, M., Shen, H., Zbuk, K., Cook, R.J., Linkins, L.A. and Major, P., 2015. Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil and irinotican (FOLFIRI) plus bevacizumab. Journal of gastrointestinal oncology, 6(3), p.274. https://doi.org/10.3978/j.issn.2078-6891.2015.025
Alhazzani, W., Al-Shamsi, H.O., Greenwald, E., Radhi, J. and Tse, F., 2015. Chronic abdominal pain secondary to mesenteric panniculitis treated successfully with endoscopic ultrasonography-guided celiac plexus block: a case report. World Journal of Gastrointestinal Endoscopy, 7(5), p.563. https://doi.org/10.4253/wjge.v7.i5.563
Javle, M., Churi, C., Kang, H.C., Shroff, R., Janku, F., Surapaneni, R., Zuo, M., Barrera, C., Al-Shamsi, H.O., Krishnan, S., Mishra, L., et al. 2015. HER2/neu-directed therapy for biliary tract cancer. Journal of hematology & oncology, 8(1), p.58. https://doi.org/10.1186/s13045-015-0155-z
Clayton, R., Wu, J., Heng, D.Y., North, S.A., Emmenegger, U., Hotte, S., Chi, K., Zielinski, R., Al-Shamsi, H., Chen, L. and Eigl, B., 2014. A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration-resistant prostate cancer. Canadian Urological Association Journal, 8(9-10), p.E583. https://doi.org/10.5489/cuaj.1891
Al-Shamsi, H.O., Al Farsi, A. and Ellis, P.M., 2014. Stage III Non–Small-Cell Lung Cancer: Establishing a Benchmark for the Proportion of Patients Suitable for Radical Treatment. Clinical Lung Cancer, 15(4), pp.274-280. https://doi.org/10.1016/j.cllc.2014.02.003
Al-Shamsi, H.O., Lau, A.N., Malik, K., Alamri, A., Ioannidis, G., Corbett, T., Adachi, J.D. and Papaioannou, A., 2012. The current practice of screening, prevention, and treatment of androgen‐deprivation‐therapy induced osteoporosis in patients with prostate cancer. Journal of oncology, 2012(1), p.958596. https://doi.org/10.1155/2012/958596
Abstract Number e1513. Al-Shamsi, H.O., Barrera, C.D., Surapaneni, R., Kang, H., Shroff, R.T., Janku, F., Krishnan, S., Zuo, M., Wolff, R.A., Kaseb, A.O. and Thomas, M.B., 2015. HER2/neu-directed therapy for biliary tract cancer. https://doi.org/10.1200/jco.2015.33.15_suppl.e15137
Kaseb, A.O., Al-Shamsi, H.O., Morris, J., Iwasaki, M., Xiao, L., Abdel-Wahab, R., Raghav, K.P.S., Hassan, M., Hassabo, H.M. and Wolff, R.A., 2015. A phase II trial of bevacizumab and erlotinib as second line therapy for advanced hepatocellular carcinoma. J Clin Oncol 33, 4088-4088(2015). https://doi.org/10.1200/jco.2015.33.15_suppl.4088
Meyers, B.M., Al-Shamsi, H.O., and Figueredo, A.T., 2015. Cochrane systematic review and meta-analysis of adjuvant therapy for stage II colon cancer. J Clin Oncol 33, 3513-3513. https://doi.org/10.1200/jco.2015.33.15_suppl.3513
Al-Shamsi, H.O., Abdel-Wahab, R., Hassan, M., Botrus, G., Shalaby, A.S., Wolff, R.A. et al. 2015. Natural History of T1N0M0 Hepatocellular carcinoma: Large scale study in the United States. Oncology, 93(4), 233-242. https://doi.org/10.1200/jco.2015.33.15_suppl.e15120
Dhesy-Thind, S.K., Meyers, B.M., Al-Shamsi, H.O., Papaioannou, A., Zbuk, K.M. and Pond, G.R., 2013. Rapid assessment of frailty prior to treatment of elderly colorectal cancer patients. J Clin Oncol 31, e20522-e20522. https://doi.org/10.1200/jco.2013.31.15_suppl.e20522
Al-Shamsi, H.O., Anjum, M., Al Farsi, A.M., Shen, H., Cook, R.J., Linkins, L.A. and Major, P., 2013. Thrombotic events in metastatic colorectal cancer patients treated with FOLFIRI plus bevacizumab. J Clin Oncol 31, e14630-e14630. https://doi.org/10.1200/jco.2013.31.15_suppl.e14630
Clayton, R., Heng, D.Y.C., Wu, J.S., Zielinski, R., North, S.A., Emmenegger, U., Hotte, S.J., Al-Shamsi, H.O., Chen, L. and Eigl, B.J., 2013. A multicenter population-based experience with abiraterone acetate (AA) in patients with metastatic castration resistant prostate cancer (mCRPC). J Clin Oncol 31, 113-113. https://doi.org/10.1200/jco.2013.31.6_suppl.113
Gastrointestinal Cancers Symposium - American Society of Clinical Oncology – ASCO 2013 meeting : J Clin Oncol 30: 2012 (suppl 34; abstr 540), Venous thromboembolism events in patients with Colorectal Cancer treated with FOLFIRI Plus bevacizumab - JCC Regional cancer centre Experience, Humaid Al-Shamsi MD, FRCPC, Major, P MD
Al-Shamsi, H.O. and Ellis, P.M., 2012. Stage III NSCLC: How many patients are really suitable for radical treatment approaches?. J Clin Oncol 30, e17532-e17532. Supervisor Dr.P.Ellis. https://doi.org/10.1200/jco.2012.30.15_suppl.e17532
Meyers, B.M., Yelamanchili, R., Rask, S., Al-Shamsi, H.O., Phillips, C.M., Papaioannou, A., Zbuk, K.M., Gu, C.S., Jeyabalan, N. and Dhesy-Thind, S.K., 2012. Utility of the Edmonton Frail Scale (EFS) in identifying frail elderly patients during treatment of colorectal cancer (CRC). J Clin Oncol 30, e14001-e14001. https://doi.org/10.1200/jco.2012.30.15_suppl.e14001
Clayton, R., Heng, D.Y.C., Wu, J.S., Zielinski, R., North, S.A., Emmenegger, U., Hotte, S.J., Al-Shamsi, H.O., Chen, L. and Eigl, B.J., 2013. A multicenter population-based experience with abiraterone acetate (AA) in patients with metastatic castration resistant prostate cancer (mCRPC). J Clin Oncol 31, 113-113. https://doi.org/10.1200/jco.2013.31.6_suppl.113
Urban Emmenegger MD4, Sebastian Hotte MD, FRCPC5, Rob Zielinski MD2, Humaid Al-Shamsi MD5, Leo Chen2, Bernhard Eigl MD, FRCPC2. General Poster Session A: colon Cancer Abstract ID: 2382
Clayton, R., Wu, J., Heng, D.Y., North, S.A., Emmenegger, U., Al-Shamsi, H.O., Hotte, S.J. and Eigl, B.J., 2012. Utilization of Radiation Therapy in Metastatic Castration Resistant Prostate Cancer Following the Introduction of Abiraterone into Clinical Oncology Practice. International Journal of Radiation Oncology, Biology, Physics, 84(3), pp.S361-S362. https://doi.org/10.1016/j.ijrobp.2012.07.954
Urban Emmenegger MD4, Sebastian Hotte MD, FRCPC5, Rob Zielinski MD2, Humaid Al-Shamsi MD5, Leo Chen2, Bernhard Eigl MD, FRCPC2.  General Poster Session A: Prostate Cancer, Abstract ID: 113
Stage III NSCLC: How many patients are really suitable for radical treatment approaches? Humaid Al-Shamsi, Dr.P.Ellis
Utility of the Edmonton Frail Scale (EFS) in identifying frail elderly patients during treatment of colorectal cancer (CRC). Brandon M Meyers, Radhika Yelamanchili, Sara Rask, Humaid Al-Shamsi, Callista Maria Phillips, Alexandra Papaioannou, Kevin M. Zbuk, Chu Shu Gu, Neera Jeyabalan, Sukhbinder K. Dhesy-Thind. Clinical Journal of Oncology 2012.
The Current practice of screening, prevention and treatment of Androgen Deprivation Therapy (ADT) induced Osteoporosis in patients with Prostate Cancer. Alshamsi,Humaid, A.Papaioannou
Ontario Thoracic Cancer Conference 2012: Stage III NSCLC: How many patients are really suitable for radical treatment approaches? Supervisor Dr.P.Ellis
Canadian society of internal medicine- Vancouve, BC Oct 2010: The Current practice of screening, prevention and treatment of Androgen Deprivation Therapy (ADT) induced Osteoporosis in patients with Prostate Cancer. Alshamsi,Humaid, A.Papaioannou
Training Tomorrow’s Oncologists at Home: Establishing the UAE’s First Hematology-Oncology Fellowship Training Program (April 2026). https://connection.asco.org/do/training-tomorrow-s-oncologists-home-establishing-uae-s-first-hematology-oncology
Establishing and Launching a Comprehensive Bone Marrow Transplant Unit in the UAE Amidst the COVID-19 Pandemic: Overcoming Barriers Through International Collaboration and Resilience. Humaid O. Al Shamsi (December 2021). https://connection.asco.org/do/establishing-and-launching-comprehensive-bone-marrow-transplant-unit-uae-amidst-covid
ASCO Post: Cancer in the Arab World: Addressing Challenges to Improve Outcomes. Humaid O. Al Shamsi (March 2022). https://ascopost.com/issues/march-10-2022/cancer-in-the-arab-world-addressing-challenges-to-improve-outcomes/
In Press: Book – Palliative Care in the Arab World (CC BY 4.0), by Springer https://www.harvard.com/book/9789819606351 This open-access book explores the growing role of palliative care in the Middle East, reflecting a global shift toward recognizing it as essential to public health and a fundamental right for patients with life-threatening illnesses. The World Health Organization (WHO) defines palliative care as a holistic approach addressing physical, emotional, and spiritual needs, extending beyond treatment to relieve suffering and improve quality of life. Delivered in hospitals, clinics, and homes, it engages families and communities through a multidisciplinary framework.
In Press: Book – Cancer Care in Africa (CC BY 4.0), by Springer
In Press: Book – Cancer in the Arab World (2nd Edition), by Springer

Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC) Jul 2011 – Present License No: 999297
Fellow of the American College of Physicians (FACP) Nov 2013 – Present Membership No: 01379227
Fellow of the Royal College of Physicians (FRCP), London, UK Oct 2023 RCP No: 171754
Fellow of the Royal College of Physicians of Ireland (FRCPI) 9 Apr 2026 RCP No: 19243685
Fellow of the Royal College of Physicians and Surgeons of Glasgow (FRCPG) 21 Feb 2024 RCPSG No: 179812
Fellow of the Royal College of Physicians of Edinburgh (FRCPE) Feb 2025 RCPE No: 884699
Combined Postdoctoral Advanced Clinical Fellowship in Gastrointestinal Oncology and Palliative Oncology Jul 2012 – Sep 2013 McMaster University, Canada
Medical Oncology Fellowship Training Program Jul 2010 – Jun 2012 McMaster University, Canada
Internal Medicine Residency Training Program Jul 2007 – Jun 2010 McMaster University, Canada
Bachelor of Medicine, Bachelor of Surgery (MB BCh BAO) with Honours University College Cork, Ireland Completed Jun 2004 BMedSc (Hons), completed Jun 2002 (awarded 2004)
Royal College of Physicians and Surgeons of Canada Medical Oncology (FRCPC) Nov 2012
American Board of Internal Medicine (ABIM) Medical Oncology Dec 2012
Membership of the Royal College of Physicians (MRCP, UK) – Medical Oncology Oct 2012
Royal College of Physicians and Surgeons of Canada Internal Medicine (FRCPC) Jun 2011
American Board of Internal Medicine (ABIM) Internal Medicine Aug 2010 Scored in the top 10%
National Board of Physicians and Surgeons (USA) Board Certified in Internal Medicine and Medical Oncology 11 Aug 2025
Sheikh Khalifa Distinguished Physician Scholarship Program 2012 – 2014 First graduate of this highly specialized UAE national program aimed at training distinguished physicians at world-class healthcare institutions.
UAE Government Scholarship – Oncology Fellowship Training McMaster University, Hamilton, Canada Jul 2010 – Sep 2013
UAE Government Scholarship – Internal Medicine Residency McMaster University, Hamilton, Canada Jul 2007 – Jun 2010
UAE Government Scholarship – Medical Education University College Cork, Ireland
Dubai Health Authority (DHA), UAE License No: DHA-O-0184997 Consultant in Internal Medicine and Medical Oncology – Active
Department of Health – Abu Dhabi (DOH), UAE License No: GD11570 Medical Oncology Consultant – Issued 03 Jan 2011; Active
Ministry of Health (MOH), UAE License No: D44393 Medical Oncology Consultant – Active
Texas Medical Board, USA Full License No: P7737 Aug 2013 – Expired
College of Physicians and Surgeons of Ontario (CPSO), Canada Full License No: 86148 – Active
Licentiate of the Medical Council of Canada (LMCC) Date: 15 Dec 2010 LMCC No: 112756
Educational Commission for Foreign Medical Graduates (ECFMG), USA Date: 25 Jul 2013
United States Medical Licensing Examination (USMLE) Steps 1, 2, and 3 Completed Aug 2013
Irish Medical Council Fully Registered (2005 – 2006) – Inactive

Chief Executive Officer Burjeel Cancer Institute – Burjeel Medical City – Burjeel Holdings – Abu Dhabi Jul 2024 – Present
Director of Oncology Services – GCC Burjeel Cancer Institute – Burjeel Holdings – Abu Dhabi Jan 2023 – Jul 2024 Led the establishment of the Burjeel oncology network across the GCC, successfully launching operations in Oman and expanding into Saudi Arabia.
Director of Oncology Services & Consultant Medical Oncologist Burjeel Cancer Institute – Burjeel Holdings – Abu Dhabi Oct 2020 – Jan 2023 Established one of the most comprehensive cancer networks in the UAE, spanning seven locations across Abu Dhabi, Dubai, Al Ain, and Sharjah. Oversaw a multidisciplinary team of 17 medical oncologists, radiation oncologists, and hematologists. Established a comprehensive bone marrow transplant unit for both adult and pediatric patients.
Professor (Visiting) Harvard Medical School (HMS), Harvard University Boston, USA Jan 2025 – Present
Visiting Scientist Dana-Farber Cancer Institute, Harvard University Boston, USA Jan 2025 – Present
Professor (Full) Ras Al Khaimah Medical and Health Sciences University Ras Al Khaimah, UAE Jun 2024 – Present
Professor (Adjunct) College of Medicine, University of Sharjah Sharjah, UAE Mar 2021 – Present (renewed May 2023)
Professor (Honorary) College of Medicine, Gulf Medical University Ajman, UAE Jun 2025 – Present
Consultant Medical Oncologist & Head of Medical Oncology Department Al Zahra Hospital, Dubai, UAE Jul 2017 – Dec 2021
Associate Professor (Adjunct) College of Medicine, University of Sharjah Sharjah, UAE Mar 2017 – Apr 2021
Assistant Professor (Full-Time) & Consultant Medical Oncologist Department of Gastrointestinal Medical Oncology MD Anderson Cancer Center, University of Texas Houston, USA Jun 2014 – Dec 2016
Assistant Professor (Adjunct) Department of Medical Oncology Juravinski Cancer Centre, McMaster University Hamilton, Canada Oct 2013 – Jun 2016
Dubai Health Authority – Advanced National Oncology Care Standards (2024) Contributed to the development and national rollout of advanced regulatory standards for oncology services across Dubai, in collaboration with the Dubai Health Authority (DHA), Prof. Humaid O. Al-Shamsi, and the Emirates Oncology Society, strengthening quality, standardization, and cancer care delivery. https://www.wam.ae/en/article/b3udh1m-dubai-health-authority-announces-advanced
Ministry of Health and Prevention (MOHAP) – National Guideline for Lung Cancer Screening and Diagnosis (2025) Played a key role through the Emirates Oncology Society in developing national guidelines for lung cancer screening and diagnosis, establishing a unified, evidence-based framework for early detection and risk stratification across the UAE. https://mohap.gov.ae/en/w/mohap-in-collaboration-with-health-authorities-and-astrazeneca-launches-national-guideline-for-lung-cancer-screening-and-diagnosis
National Multidisciplinary Committee for Cancer Case Assessment (2025) Contributed to the establishment of the National Multidisciplinary Committee for Cancer Case Assessment under Ministerial Decree No. (20) of 2025, formalizing multidisciplinary decision-making and strengthening coordinated cancer care at the national level. https://mohap.gov.ae/en/w/ministerial-decree-no.-20-of-the-year-2025-regarding-the-the-criteria-for-establishing-the-national-multidisciplinary-committee-for-cancer-case-assessment-available-in-arabic-
Clinical Supervisor – Internal Medicine Residents Tawam Hospital, Al Ain, UAE Jul 2017 – Present
Clinical Supervisor – Fellows and Residents MD Anderson Cancer Center, Houston, USA Jun 2014 – Jan 2017
Planner and Organizer – Medical Oncology Journal Club McMaster University Jul 2012 – Jun 2013
OSCE Examiner – Undergraduate MD Program McMaster University Nov 2007 & Jun 2008 Participated as an examiner in OSCE examinations to enhance evaluation and feedback skills.
ECG Crash Course Instructor Dec 2008 & Apr 2009 Prepared and delivered a 6-hour workshop for junior residents and medical students, covering key aspects of ECG interpretation with excellent learner feedback.
Providing ongoing support to junior UAE physicians: Dr. Aydah Alawadi, Mentorship throughout internal medicine training and support to gain fellowship training at MD Anderson Cancer Center, Houston, Texas, USA. Due to complete Medical Oncology fellowship training in June 2019 and planning to do Breast Fellowship at MD Anderson Cancer and Dr. Zaki Ajlan, Mentorship throughout medical school training, one to one advice and support regarding how to choose subspecialty for postgraduate training. Dr. Ajlan was matched to Stanford University internal medicine program, Stanford, California, USA in March 2018 with guaranteed medical oncology fellowship upon the completion of the internal medicine residency program.
Combined Chemo-immunotherapy in NSCLC is it ready for the prime time? Clinical Case Discussion, Immuno-Oncology Summit, Dubai, UAE, December 15, 2019
SP147 assay PDL-1 interpretation in clinical practice (NSCLC and GU cancers) - PDL-1 workshop for pathologist from the gulf region (KSA, Iraq, UAE), Dubai, December 16, 2019
Colorectal and breast cancer guidelines workshop – The gulf federation for cancer control, Member of the gulf federation for cancer control taskforce for colorectal and breast cancer guidelines, Kuwait City, Kuwait, Nov 26-27, 2018
The role of bevacizumab in advanced colorectal cancer, Journal club, Dubai, UAE, Nov 20, 2019
Defining the Genomic Landscape of Colorectal Cancer, Emirates Oncology Conference, Abu Dhabi, Nov 17, 2019
Update in the management of advanced colorectal cancer in the second line setting, Oman Cancer conference, Muscat, Oman, Oct 12, 2018
Defining the Genomic Landscape of Colorectal Cancer, UAE Cancer congress, Dubai, UAE, Oct 6, 2017
Advances in the management of metastatic castrate resistant prostate cancer, UAE Cancer congress, Dubai, UAE, Oct 6, 2019
Sharjah Morning program interview, World Cancer Day, explained to the public in simple language the importance of early cancer screening. https://www.youtube.com/watch?v=xE3KEyJpygs
Friends of cancer event – Early cancer screening – a talk targeted to the general public audience titled “Early cancer detection, When and How?” 20-Jan-2018.
Free medical consultation for Cancer patient at Al Zahra Hospital – Dubai Jul 2017 - Present

President, Emirates Oncology Society (EOS) Nov 2018 – Present https://eos-uae.com/
Chairman, UAE Oncology and Hematology Fellowship Training Program National Institute for Health Specialties May 2022 – Present
Member, UAE National Committee Present
Society Chair, Gulf Cancer Society Present https://gulfcancersociety.com/
Chairman, Colon Cancer Guidelines Committee (MENA) – NCCN Dec 2021 – Present
President, Gulf Oncology Society Dec 2021 – Jul 2025
Member, Lung Cancer Policy Network Present https://www.lungcancerpolicynetwork.com/members/humaid-al-shamsi/
Member, Steering Committee – National Cancer Control Indicators Ministry of Health, UAE Jan 2018 – Present
Member, Department of Health Oncology Task Force Jan 2019 – Present
Editorial Board Member, Journal of Global Oncology Aug 2017 – Present
Member, Emirates Oncology Society 2017 – Present
Member, International Society of Gastrointestinal Oncology (ISGIO) Jan 2014 – Present
Member, American Society of Clinical Oncology (ASCO) Nov 2013 – Present
Member, European Society for Medical Oncology (ESMO) Nov 2013 – Present
Fellow, Royal College of Physicians and Surgeons of Canada (FRCPC) Jul 2011 – Present
Fellow, American College of Physicians (FACP) 2007 – Present
Member, Canadian Medical Protective Association 2007 – Present
Member, UAE Medical Association 2006 – Present

Our Experts

Prof. Dr. Humaid Alshamsi

Biography

Professional Profile.

Awards & Achievements

Research and Publications

Education and Training

Expertise

Membership